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The first description of scurvy is accredited to
Hippocrates who reported symptoms of the disease in soldiers.
It ravaged the ranks of the armies of the Crusaders, but it
was as a mariners8 disease that it was most prominent in the
medieval world.
The efficacy of watercress, Icelandic scurvy grass and
citrus fruits in curing symptoms had been recognised several
centuries ego, but the interpretation of the function of
these vegetables and fruits was not achieved until compar¬
atively recently. At the beginning of the twentieth century
it was realised that scurvy was one of a group of "deficiency
diseases" that could be cured lay the feeding of small amounts
of a "vitamin" or "accessory food factor." The appropriate
vitamin was termed "vitamin C" and recognised to be found in
quantity in citrus fruit juices.
The vitamin was isolated from lemon juice and its
chemical nature established in the years 1930-33. It was
found to be a strongly reducing hexnronie acid, subsequently
being termed "ascorbic acid" by agreement between the
principal workers in the field. Synthesis of the biologic¬
ally active ascorbic acid from xylosone, itself completely
inactive as an antiscorbutic, finally established conclusive¬
ly that ascorbic acid was the antiscorbutic dietary factor
(Chick, /
2.
(Chick, 1953} Hirst, 1953; King, 1953).
OXIDATION OF ASCORBIC ACID TO DEHYDROASCORBIC ACID..
The structural formula of ascorbic acid was established
by several workers, chief amongst them being the Birmingham
School in this country (Herbert, Hirst, Percival, Reynolds
and Smith, 1933) and Karrer (1933) and Micheel (1933) on the
Continent. Their experimental material was ascorbic acid
prepared from adrenal glands and paprika supplied largely by
Szent-Gyflrgyi. They found the formula to be as shown below j
L-ascorbic acid is the antiscorbutic form.
The chemical feature of ascorbic acid which is of most
interest to the biochemist is its susceptibility to oxidation
in which molecular oxygen is the final hydrogen acceptor.
Though the reaction has been widely studied, knowledge of the
course of the oxidation, which culminates in the formation of
water and carbon dioxide, is scanty and incomplete. Haworth's
colleagues in 1933 were the first investigators to produce an
adequate account of the steps involved (Herbert et 1.. 1933)4




ascorbic acid, which can be readily reduced to ascorbic acid
again by such agents as hydrogen sulphide (Tillmans, Hirsch
and Dick, 1932a; Johnson, 1933) and hydriodic acid,
Dehydroascorbic acid is very labile in solution and at pH
values greater than 4 is converted irreversibly in a nan-
-oxidative reaction to 2i3 di-ketogulonic add. Subsequent
stages in the conversion to water and carbon dioxide have not
been fully worked out but some are known to be non-oxidative
in character. Oxalic acid and threonic acid are intermed¬
iate products in the course of the reaction. No other
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The oxidation of ascorbic acid is influenced by hydrogen
ion concentration, the rate increasing with increase in pH.
The rate also increases with an increase in temperature.




PROFESS OF DEHIDRQA3CORBIC ACID.
The chemistry of debydroascorbic acid has been little
studied, due partly to its lability and the difficulty of
estimation, and partly to the fact that it appeared to be
of secondary importance compered with the more stable reduced
ascorbic acid. (When referring to ascorbic acid in contra¬
distinction to dehydroascorbic acid, it is customary to use
the term "reduced ascorbic acid" to prevent confusion.)
Moll and Wieters (1936) reviewed the chemistry of this first
isolated oxidation product and also gave a method for its
preparation in aqueous solution by oxidation of ascorbic acid
v/ith benzoquinone. Preparation of the solid substance was
not accomplished until 1948 when Kenyon and Munro (1943) pre¬
pared it from ascorbic acid by iodine oxidation. They also
reviewed some of its physical characteristics. Pecheror
(1951) published a modified version of their method, using
chlorine as the hydrogen acceptor.
When ascorbic acid solution is submitted to mild oxid¬
ation, the dehydroascorbic acid so produced can bo reduced
quantitatively to ascorbic acid again by hydrogen sulphide
treatment, if this is carried out immediately. If the
solution of dehydroascorbic acid is allowed to stand before
HgS reduction is carried out, the recovery of the original
ascorbic acid is less than quantitative, showing decompos¬
ition of dehydroascorbic acid has occurred as the solution
stands. /
5.
stands. The decomposition is progressive vrith time and for
good recovery of the original ascorbic acid it is necessary
to treat with hydrogen sulphide in as short as possible time
after formation of the solution of dehydroascorbic acid.
Moll and Wieters (1936) also investigated the decompos¬
ition of dehydroascorbic acid end showed it to be non-oid.dat¬
ive, talcing place as rapidly in an anaerobic as in an aerobic
atraosphere. They showed that the decomposition of dehydro-
ascorbic acid was affected by temperature, the rate of
decomposition increasing with increase in temperature. If
stored at -4 C, a 6% solution of dehydroascorbic acid do-
composed only slowly; 95% of the theoretical concentration
of ascorbic acid was recovered after HjS reduction, 5 day3
after its preparation. Ho matter how far the temperature
was lowered, however, these authors reported that complete
stability of dehydroaseorbic acid solution was never achieved.
As decomposition of dehydroaseorbic acid proceeds there
appears at the same time a substance which, like reduced
ascorbic acid, reduces dichlorphenolindophenol, silver
nitrate and iodine readily. It is not, however, anti¬
scorbutic, and so is not the original reduced form of the
vitamin. There is never more of the substance formed than
the equivalent of 10^ of the original dehydro ascorbic acid.
Moll and Wieters have suggested that it is one of the
reductones, a class of substances which has similar reducing
-
properties to ascorbic acid.
The /
6.
The main characteristics by which dehydroascorbic acid
is identified are:
1) Its ready reduction to ascorbic acid, and
2) The formation of a phenylhydraaone on dinitrophenyl-
hydrazine treatment.
Reaction 2) was first observed by Herbert and his
colleagues (Herbert et al.. 1933) and by Ohio (1934). The
bydrazono is reported to be formed only after the conversion
of dehydroascorbic acid to diketogulonic acid, but the con¬
ditions of the reaction favour this hydration (Penney and
Zilva, 1943).
According to Moll and Wieters (1936), dehydroascorbic
acid also reacts very smoothly with various phenylenadiamines
to give solid yellow condensation products.
FACTORS AFFBCTIilG THE OXIDATION OF ASCORBIC ACID.
Since ascorbic acid was readily oxidisable and was known
to be very generally distributed in the animal body and in
plants, it seemed probable that this compound might be
concerned in the maintenance of oxidation-reduction equil¬
ibrium in cellular reactions. This postulate prompted
various workers to study the kinetics of the oxidation in
aqueous solution, but at first with indifferent success.
It was a sluggish system in which to carry out potential
determinations and the instability of dehydroascorbic acid
hindered determinations further. There was no satisfactory
establishment /
establishment of the thermodynamic reversibility of the
oxidation of ascorbic acid to delivdroascorbic acid until the
work of Barron. De Meio end Klemperer (1936b). These
investigators concluded that, in pure solutions, ascorbic
acid was only eatoxidisable in alkaline media, the autoxid¬
ation increasing with increase in pH, Borsook and his
co-workers (Borsook, Davenport, Jeffreys and Warner, 1937)
succeeded in establishing the potentials for the oxidation
and showed conclusively that AA = KIA + 3.H* was the only
step in the whole oxidation chain that was physiologically
reversible,
Barron et si. (1936b) were also the first to estimate
quantitatively the great sensitivity of the system to
metallic ions. They reported that there was a catalytic
action in a solution containing a concentration of cupric
ions as low as 46pg./litre, The system was also found to
be very sensitive to ferric ion catalysis. Since both
these metallic ions ere found widespread biologically in the
free state and protein-bound, there ha3 been much interest
in their effect on the kinetics of the oxidation. Most
work reported in the literature is on copper catalysis.
The conclusion is that copper enters the reaction as the
cupric salt, is reduced to the cuprous form with accompanying
formation of dehydroascorbie acid and is eventually regener¬
ated in the original cupric form, hydrogen peroxide also
being /
3.
being produced (Dekker and Dickinson, 1940j Silverblatt,
Robinson and King, 1943), The copper catalysis is very
sensitive to pH, and according to Weissberger and LuValle
(1944), the oxidation of the monovalent ion of ascorbic acid
is the one which is sensitive to the catalytic action of
copper. Trie presence of the dienol grouping
OH OH
I I
- C = C -
appears to be necessary for effective copper catalysis.
Numerous anions affect the sensitivity of ascorbic acid
solution to oxidation, some by acting directly on the vitamin
and others indirectly through their action on eupric and
ferric ions, Trichloracetate was early recognised as a
stabilising anion, as was the more efficient metaphosphate.
The inhibitory action of the latter acid on copper catalysis
of the oxidation is exploited in the usual method for
estimating the reduced form of ascorbic acid, Fujita and
Iwatake (1935) introduced the us© of metaphosphate and it
was further examined by Musulin and King (1936) and by
Lyman, Schultze and King (1937). Lyman and his co-workers
showed that its inhibitory action depends upon a depression
of the copper ion concentration, and in addition, upon a
lowering of the pH of the solution. They reported that in
buffered solutions near pH 7, there is no appreciable inhib¬
ition of ascorbic acid oxidation by the addition of meta¬
phosphate. /
9.
phosphate. They also demonstrated the accelerating action
of chloride on the oxidation, a fact also pointed out by
Moll and Wieters (1936). Mapson (1941. 1945) extended this
work end showed that the h,elides as a class increase the
rate of ascorbic acid oxidation, iodide being the moat
effective; fluoride, however, is inactive. The anion
increases the rate of the following reaction in the catalytic
oxidations
2Cu++ + AA = 2Cu+ + DM + 2H+
O-iodobenaoic acid has also been reported to increase
the oxidation rate, the effectiveness varying with the buffer
used (Eoileman and Caraway, 1953).
Various buffers have been examined for their action on
the oxidation. In general, it is believed that buffer
solutions stabilise ascorbic acid solutions to a certain
degree (Moll and Wioters, 1936). It has been claimed that
the rate of oxidation of ascorbic acid at pH 7 is less in
the presence of citrate than in the presence of phosphate
(Sukhonkc, Priss and Radushkevlch, 1951). Rosenfeld (194-3)
has suggested that in the presence of phosphate, at pH 7,
dehydroascorbic acid is not converted to dlketogulonic acid,
but that there is a scission of the 6-cerbon chain with a
quantitative formation of oxalic acid. Finally, De Caro
and Giani (1934) have mentioned the stabilising action of
Ringer's solution on the system.
E$ /
THE EXISTS;?CS OF I!OKQD£KYDROASCQRDIC ACID.
Be333onoff and Wolossyn (1936) employed Martini and
Bonsignore1s (1934) method for the estimation of ascorbic
acid, using methylene blue. They found in the course of
their -work that the oxidation of ascorbic acid by the dye
•took place in two stages, and on these grounds suggested the
existence of an intermediate which they called monodehydro-
ascorbic acid. The structure of the intermediate they
suggested to be as followss
(Beassonoff and Wolosayn, 1936)
In 1939, these authors (Bezssonoff and Woloszyn, 1939)
proposed a method for the estimation of monodehydroascorbic
acid in tissues, using both indophenol and methylene blue
estimations. They claimed that indophenol was reduced by
ascorbic acid and by monodehydroascorhic acid, while methyl¬
ene blue reduction was due only to reduced ascorbic acid.







subtracting the methylene blue value from the indophenol
value.
Dekker and Dickinson (1940) and Silverblatt et al.
(1943) reported that the copper catalysed oxidation of
ascorbic acid by molecular oxygen was a two-stage reaction.
Weissberger and LuValle (1944) suggested that the inter¬
mediate in this oxidation was a free radical. Two of these
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Such a free radical would accept one electron very
rapidly to form the reduced ascorbic acid ion5 or would
equally rapidly form dehydroascorbic acid v/ith the loss of
another hydrogen atom and rearrangement of the electron
field.
The oxidation of tyrosine was found to be impaired in
scorbutic guinea-pigs (Sealock and Silberstein, 1940), in
premature babies (Levine, Gordon and Marples, 1941) and in
scorbutic /
scorbutic adults on a high tyrosine diet (Rogers and Gardner,
1949). The defect was shown by a high urinary excretion of
"tyrosyl" compounds, which was decreased on administration
of ascorbic acid.
Heuberger (1949) suggested that tyrosine was attacked
in normal biological oxidation by a cationoid reagent at
the ortho- and oara- positions relative to the hydroxyl
group. This stage seemed to be the one sensitive to the
lack of ascorbic acid. I»loyd and Sinclair (1953) extended
this hypothesis with their suggestion that the responsible
*
cationoid reagent might be the free radical monodehydro-
ascorbic acid.
These latter authors also postulated that vitamin C
acted in the form of the free radical in relation to the
metabolism of the adrenal cortex, and to the secretion of
the adrenal cortical hormone.
The existence of such a free radical would explain
biological reactions of vitamin G otherwise difficult to
interpret. However, Lloyd and Sinclair (1953) stressed
the need for further experimental work before accepting




BIOLOGICAL OXIDATION OF ASCORBIC ASID.
Sines so rsueh work has shown the susceptibility of
ascorbic acid in aqueous solution to oxidation, it is
obviously of the greatest importance to estimate the effect
of biological media on its stability.
Ascorbic acid was isolated from biologies! material in
the reduced form. When solutions of the vitamin were
incubated with various tissue extracts or biological fluids,
the vitamin was stable far longer than in pure solution
(Quastel and Wheatley, 1934; Kellis and Zilva, 1935;
Kswson, 1935). Green (1933) postulated the existence of
a stabilising mechanism within the body which was responsible
for this fact. Do Caro and G-iani (1934) pursued this idea
and suggested the involvement of glutathione. Mawson (1935)
presented the theory that cysteine and cystine were also
concerned in the stabilisation but he folt this was not the
entire explanation. According 'to Keliie and Zilva (1935)
aii explanation of the stabilising action of tissue extracts
could bo sought in their inhibition of copper and iron
catalysis.
Mawson's (1935) conclusions, as they stood, vera of
little significance, since they were based on work done
under non-physiological conditions. In 1936, Barron and
his colleagues (Barron, Barron and KLemperor, 1936a) realised
this and so re-investigated the possibility that glutathione
was /
14.
was a biological stabilising agent of ascorbic acid. They
studied various fluids - cerebrospinal fluid, vitroous
humour, gastric juice, urine, serum and whole blood - and
concluded that in them stabilisation of aseorbie aoid
occurred because of an inhibition of copper and iron, and
also that glutathione helped in this way to stabilise the
vitamin by forming an inactive unionised copper-glutathione
complex. They reported the same degree of protection of
ascorbic acid in blood serum and in whole blood and so
concluded that the cellular portion of blood had no especial
protective capacity. This was opposite to the conclusions
of Kellie and Zilva (1935) who stated that leucocytes were
the only blood components inactive in the stabilisation of
ascorbic acid. Borsook et al. (1937) also disagreed with
Barron's results (Barron et al.. 1936a) in their finding of
the greater protection from whole blood than from serum.
Later work demonstrated that whole unhaemolysed blood was
indeed more efficient than serum or plasma in the stabilis¬
ation of ascorbic acid (Kassan and Roo, 1940; Heine®ann,
1941; Golden end Garfinkel, 1942). Borsook and his co¬
workers (Borsook et al.. 1937) also reported that glutathione
could stabilise ascorbic acid in solution, but attributed
this to a direct reducing action on any dehydroascorbic acid
that might form.
While /
While glutathione is regarded generally as the principal
biological stabilising factor, various other substances have
been considered. Giri and Krishnaraurthy (1941) suggested
the possible protective action of some purines and of creatini
Nevertheless, glutathione is the substance most generally
accepted as stabilising agent for ascorbic acid in biological
fluids and extracts. Indeed, Saent-GySrgyi (192S) mentioned
that it could reduce his haxoronic acid and, as has been
indicated, various authors (De Csro and Gianl, 1934; Manson,
1935; Goldstein and Volkenzon, 1938) regarded it as the
principal, while others claimed it to be the only factor in
the stabilisation (Borsook et at., 1937).
The fact that the biological distribution of glutathione
is very similar to that of ascorbic acid is an additional
support to this idea. The work on their interdependence
has progressed further in the field of plant metabolism,
where several investigators have established a stoichiometric
relationship controlled by ascorbic acid oxidase. This
enzyme is believed only to occur in plants (Hopkins and
Morgan, 1936; Grook and Hopkins, 1933; Crook, 1941).
In animal metabolism, the situation is less clearly
defined. In 1935, Bersin and his colleagues (Bersin, K8ster
and Jusatz, 1935) showed that scurvy depleted the level of
ascorbic acid and glutathione in the guinea-pig adrenal, and
that restoring the deficient vitamin to the diet raised the
level /
level of both in the gland. They found no change in blood
glutathione in scurvy. On the other hand, Prunty and Vass
claimed a fall in human blood glutathione occurred as the
ascorbic acid level rose (Prunty end Vass, 1943). Although
not contradictory, these results seeia hardly compatible.
Oxidation of ascorbic acid does occur in biological
media. Haoraochromagens oxidise ascorbic acid very readily
(Barron et gl.. 1936a; Lemberg, Legge and Lockvood, 1939)•
This occurs only in the presence of copper ions. When
whole blood is .laked, the resulting release of haemoglobin
into a medium containing copper ions is responsible for
complete oxidation of all ascorbic acid present in the blood
and subsequent errors in estimation.
There is no evidence as yet to suggest a parallel
enzyme to ascorbic acid oxidase in animal tissues. In 1937,
Stotz and Ms fellow workers (Stotz, Harrer, Schultze and
King, 1937) oxidised ascorbic acid by adding to it a brei
prepared from guinea-pig livers. The oxidation was not due
to the copper content of the brei. They suggested the
reaction mechanism was by means of the indophenol oxidase-
cytochrome c enzyme system, since cyanide, carbon monoxide
and azide all inhibited the oxidation. Ruffo (1952)
reported that a paste formed from the livers of fasting rats
accelerated ascorbic acid oxidation in alkaline conditions.
However, this work is of little physiological importance.
BIOLOGICAL /
BIOLOGICAL KEEKJCTIOK OF DjjYDROASCORBIC ACID,
a) In vitro.
Not only do tissues such as liver, kidney and adrenal
stabilise ascorbic acid, but they also reduce dehydroascorbie
acid to reduced ascorbic acid. This has been reported by
several workers, in particular Borsook and his colleagues
(Borsook 0t al». 1937) and Schultse, Stotz and King (1937).
Both stabilisation and reduction are generally recognised to
be due to the same reaction mechanism. Although Borsook
et al. (1937) reported ascorbic acid to be ranch more stable
in whole blood than in plasma or aqueous solution, they
failed to find any reduction capacity in whole blood and
similarly, found plasma to be inactive. The inability of
plasma to reduce dehydroascorbic acid has been amply con¬
firmed by Plant end Billow (1935) end by Schultze et al.
(1937) but the latter, unlike Borsook et al. (1937) found
that whole blood and erythrocytes' suspensions would reduce
added dehydroascorbic acid. This has been confirmed by
Lloyd (1951), Lloyd and Parry (1954) end by the present
writer.
While most authors regard the reduction of dehydro¬
ascorbic acid in animals as due wholly or in part to the
action of glutathione, there has been some difference in
views as to the reaction mechanism concerned. Roe and
Barnum (1936) showed fluoride inhibited the reduction of
dehydroascorbic /
dehydroascorbic acid and that plasma coagulated by heat was
inactive with respect to the reduction. On this basis,
they claimed that the reduction was enzyme. However,
Plaut end Billow (1935) and Sehultze et al. (1937) demonstrated
that plasma could not reduce dehydroascorbic acid under
ordinary conditions. Also fluoride is a non-specific
inhibitor. On these grounds, Roe and Bsrnum's (1936)
claim has little experimental support and it remains an
open question that the reduction is enzyme. Subsequent
workers are agreed on the participation of sulphydryl groups,
since specific -SH poisons, iodoacetate and arsenite, are
found to inhibit the reduction completely (Borsook et al..
1937; Schultze et al.. 1937).
The reaction actually taking place in biological media
between dehydroascorbic acid and glutathione does not appear
to be the most obvious one expressed in equation (l).
OTA + 2GSH = M + GSSG (l)
This is a third order reaction and would take place much
more slowly than the results obtained with biological systems
suggest actually happens. Schultze and his fellow workers
(Schultze et al.. 1937) found the relationship between the
two substances did not fit equation (l). Mm/son (1935)
noted that far less glutathione was used in dehydroascorbic
acid reduction than was needed on the basis of this equation.
Borsook and his colleagues (Borsook et al.. 1937) suggested
that /
that there wae a glutathione-dehydroasccrbic acid complex
formed but gave no further details of its possible structure
or reactivity. Kirikawa (1944) claimed that there was
another reducing mechanism in animal tissues, in addition
to glutathione and fixed -SI. This unidentified substance
he reported to be non-enzyraic and heat-stable. It was
also claimed to be i/ater-soluble and ether-insoluble.
There are various factors said to influence the extent
of the reduction. If the concentration of glutathione in
the medium is increased, then the reduction increases. An
increase in pH has the same effect (Borsook et al«. 1937)*
Schultze et al. (1937) found that an increase in ascorbic
acid concentration caused a fall in the amount of dehydro-
ascorbic acid reduced.
There is obviously some mechanism in biological systems,
other than the glutathione present, which is responsible for
the reduction of dehydroascorbic acid. The problem arises
whether such a mechanism acts independently of glutathione
or whether its part in the reduction is closely related to
the reducing action of glutathione, possibly in the regener¬
ation of reduced glutathione from the oxidised form, and so
in the maintenance of the concentration of the tripeptide•
The previous condition of the animal whose tissues are
under examination may be important. A decreased reduction
was /
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was reported (Vinokurov and Silakova, 1944j Matusis, 1951)
in the tissues of people who had been chronically ill prior
to death, coopered with those whose health had been good.
Schroll (1939) reported that tissues from animals trained
on a treadmill reduced dehydroascorbic acid raore rapidly
than those from untrained animals. Parrot and Gazave (1951)
claimed that liver from guinea-pigs pre-fed on a cateehol-
-rich diet had an increased reduction capacity,
k) In vivo.
The reversibly oxidised form of vitamin 0 was recognised
to be antiscorbutic in humans and guinea-pigs even before the
chemical nature of the vitamin was fully established (Zilva,
1928; Tillmans, Hirsch and Hirsch, 1932b; Deraole, 1933;
Hirst and Zilva, 1933). Bioassay on guinea-pigs (Fox and
Levy, 1936; Moll and Wieters, 1936; Gould and Schwachman,
1943), human excretion studies (Johnson and Zilva, 1934;
De Hitter, Cohen and Rubin, 1951) and plasma level and
urinary excretion examinations in humans (Todhunter, McMillan
and Shmke, 1950; Clayton, McSwiney and Prunty, 1954) have
provided ample support for this.
There is thus corroboration by in vivo experiments for
the conclusion based on results from in vitro experiments
that a biological mechanism for reducing dehydrosscorbic
acid does exist. There is, however, a certain amount of
controversy about the efficiency of this mehhanism. Roe
and /
21.
and Barnum (1936) state that debydroascorbic acid is only
25% as active as ascorbic acid, while Borsook at al. (1937)
report oxidised orange juice in humans is as efficiently
utilised as ordinary orange juice. Gould and Schwachman
(1943) find 80$ utilisation, weight for weight, of dehydro-
ascorbic acid administered to guinea-pigs, and analysis of
the results of Todhunter and hhr colleagues for humans
suggests a similar value (Todhunter et al.. 1950).
Analysis of tissue levels after dehydroascorbic acid
administratlon indicates a similar lessening of efficiency
with regard to ascorbic acid storage (Billow, 1936j Fox and
Levy, 1936j Damron, Monier and Roe, 1952). Penney and
Zilva (1943) suggest that if small amounts of dehydroascorbic
acid are given, there is a quantitative conversion to
ascorbic acid and utilisation as the vitamin, but on admin¬
istration of large amounts there is a decrease in the
utilisation. They attribute this to a delay in absorption
of dehydro&scorbie acid, with consequently greater opportun¬
ity for the opening of the lactone ring to form diketogulonic
acid. This substance is realised to have no antiscorbutic
activity at all (Hirst and Zilva, 1933} Borsook et al..
1937; Penney and Zilva, 1943). The presence of considerable
amounts of di-ketogulonic acid in Roe and Bsrnum's (1936)
"dehydr0ascorbic acid" preparation would explain the low
figure thsy quote for it3 biological efficiency.
On /
On the basis of this work, it seems improbable that
dehydroascorbic acid is absorbed unchanged, even in part.
However, Liaksweiler (1954) reports the presence of 0.2mg./
100ml. deliydroasearbic acid in blood after its administration
to humans, as against Q.OSiag./lOOml. after a parallel dosage
of ascorbic acid in comparable time. It is doubtful if
these results are entirely reliable since there are no
details of the method of estimation. The author's report
of significant excretion of dehy&roascorbic acid after its
ingestion is in conflict with the work of Johnson and Zilva
(1934) and De Ritter et al. (1951) who state there is no
appreciable amount of urinary dehydroascorbie acid in similar
circumstances.
It can safely be stated that by far the greater part of
dehydroascorbic acid, administered to either guinea-pigs or
humans, is reduced in the body and utilised as ascorbic acid.
EXISTENCE OF ASCORBIC AGIO ASP DEI■ IHRCASCQuBIC ACID IN BLOOD.
The discovery of the chemical nature of the scorbutic
vitamin promoted the search for it in biological material.
It had been isolated both from plant and animal material
prior to the elucidation of its chemical identity, and this
prompted investigation of its presence in blood and urine.
The primary investigation technique utilised dichlorphenol-
indophenol which had pz-oved a satisfactory rule-of-thumb
agent /
agent in the isolation work on lemon juice (Tillmans, 1930).
The reduction of the dye was, however, by no means specific
for ascorbic acid, and so it was realised that conclusions
based on this tost alone were insufficient. Van Eekelen,
Emmerie, Josephy and Wolff (1933) showed that filtrates
prepared with trichloracetic acid from guinea-pig blood,
2
and reduced with hydrogen sulphide, could reduce indophenol,
after excess hydrogen sulphide was removed. This capacity
was lost if the guinea-pigs became scorbutic, and was
increased if the guinea-pigs had previously been on a high
ascorbic acid diet. When the filtrate was treated with
lead acetate in alkaline solution, a substance was precipit¬
ated which di33olved in acid to give a solution reducing
indophenol. Since ascorbic acid behaved true, van Eekelen
et al. (1933) concluded this substance in the blood filtrate
was the vitamin. Similarly, a substance was precipitated
and examined in urine and their conclusion that this, too,
was ascorbic acid was substantiated by its isolation from
urine as the dinitrophenylhydraaone by Drum m ^Scarborough
and Stewart (1937).
There has been no serious quarrel with the concept that
ascorbic acid i3 present in blood, but concerning dehydro-
ascorbic acid, opinions ore divergent. Until a completely
satisfactory method is devised for the specific estimation
of ascorbic acid, distinguishing it from its oxidation
products, /
products, it seems the controversy about the presence of
dehydroascorbie acid i-ri.ll continue.
Some early workers believed the vitamin was found in
its entirety in the dehydro-form in blood (van Eekelen et al..
1933; Plant and Billow, 1935; Pujita and Ebihara, 1937),
while others stated that there was no dehydroaseorbic acid
in blood at all (Kellio and Zilva, 1936; Borsook et al..
1937; Lund and Elm'by, 1938). More recently, it has been
recognised that it is impossible to be categorical about its
presence or absence while methods of estimation are still
relatively unspecific. The concensus of recent opinion
seems to be that a little of the dehydro-form of the vitamin
may be found in the blood, with an increase in the amount in
various pathological conditions (Lloyd, Sinclair and Webster,
1945; Chen and Schuck, 1950; Davey, Wu and Storvick, 1952;
Banerjee and Belavady, 1953 ; Stewart, Horn and Robson, 1953;
Linksweiler, 1954). While it is rash to state definitely
the actual amount, it seems highly improbable that in plasma,
it is ever much in excess of 0.20-0.25mg./l00ml. and more
usually it is in the range 0.05-0.15mg./l00ml.
Analysis of the white blood cell-platelet fraction of
blood - Orsndon's "huffy layer" - has not been concerned
with the possible presence of dehydroaseorbic acid and the
methods used for the estimation of the vitamin in this
fraction do not permit a differentiation between the reduced
and /
and reversible oxidised forms of the vitamin. Kellia and
Zilva (1935) reported that this portion of the blood could
not stabilise ascorbic acid, and Lloyd (1951) suggested
that leucocytes could oxidise the vitamin. This suggested
that in this portion of blood, the vitamin was found to a
large extent, if not wholly, as the dehydro-form.
Relatively few analyses have been carried out for
ascorbic acid or dehydroascorbie acid on the erythrocyte
portion of blood and here again there appears to have been
no attempt to estimate the dehydro-form itself. Technical
difficulties are possibly responsible for this omission.
It is improbable that much of the vitamin in the
erythrocytes is present in the reversibly oxidised form.
With methods currently in use, estimations on whole blood,
with subsequent corrections for plasma levels of the two
forms of the vitamin, are not sufficiently reliable to permit
confirmation of the presence or absence of the dehydro-form
in erythrocytes. Although an exhaustive study has not been
carried out, the results obtained from erythrocyte determin¬
ations in the course of the work for this thesis suggest
that there is virtually no dehydroascorbic acid in this
fraction of human blood.
LMSAGS /
PASSAGE 0:n ASCORBIC ACID AHD DEHYDROASCORBIC ACID ACROSS
BLOOD CELL MEMBRANES.
Results of the investigations on the ability of ascorbic
acid to pass across the blood cell membrane were at first
inconclusive and confused. There was general agreement that
such a transfer took place in vivo (Heinemann, 1933; Grandon,
Lund and Dill, 1940), but the results were not so clear-cut
in In vitro work. Borsook et al. (1937) stated that
ascorbic acid added to blood was still to be found in its
entirety four hours later in the plasma, while Heinemann and
Hald (1940) and also Butler and Cushmaa (1940) claimed that
a slow passage of ascorbic acid took place from the plasma
into the cell and that this was enhanced by shaking. Later,
Heinemann (1941) qualified his reports and showed that the
presence of leucocytes was necessary for this transfer to be
effected. The transfer found to occur in vivo was
explained, therefore, since there were always leucocytes
present. Lloyd (1951) verified that ascorbic acid was
taken up by leucocytes in vitro and stated that, within them,
it was oxidised to dehydroascorbic acid.
Golden and Sargent (1952) showed that ascorbic acid, did
not pass into erythrocytes in vitro. Dehydroascorbic acid,
on the other hand, was observed to pass quickly into the
erythrocytes in vitro and there to undergo partial reduction
(Panteleeva, 1950; Lloyd, 1951; Lloyd and Parry, 1954).
The /
The concentrations reached within the cell were found to be
very much in excess of those in plasma. Ponteleeva (1950)
stated that the exchange between erythrocytes and plasma
was largely in the form of dehydroascorbic acid. If this
is so, then the reports that ascorbic aeid does not pass out
of the erythrocyte are explained (Helnamaim, 1940 j Golden
and Sargent, 1952).
This capacity for the erythrocyte to reduce dehydro-
ascorbie acid nay be the explanation of the report by
Langhem (1950) that the intravenous injection of dehydro¬
ascorbic acid in the rabbit results in en increase in
reduced ascorbic acid in the aqueous humour.
DEJiYDR0A3C0RBIC ACID DIABETES.
Several workers reported a lowered glucose tolerance in
scurvy in experimental animals (Sigsl and King, 1936 J
Banerjee and Ghosh, 1947), although this was not found in
the ease of experimental human scurvy reported by Crandon
et al. (1940). An increase in tissue dehydroascorbic acid
was reported in the same condition in guinea-pigs by
Banerjee, Deb and Belavady (1952). This suggested a
possible connection between diabetes and dehydroaocorbic
acid.
There are strop; structural and chemical resemblances
between dehydroascorbic acid and alloxan, a substance with
recognised /











Both are relatively unstable at physiological pHs, both
give the Strecker reaction with amino- acids, and both
combine readily with sulphydryl compounds. This was
demonstrated for dehydroascorbic acid by Drake, Smyths and
King (1943) and for alloxan by Patterson, Lazarow and Levey
(1949)♦
Alloxan diabetes h&3 been studied and confirmed by very
-many workers in several species of animals since the original
report of the production of diabetes in rabbits by Dunn,
Sheahsn and McLetchie (1943). The diabetes is a result of
the necrotic action of alloxan on the/%-cells of the Islets
of Langerhans. The mechanism of the action is as yet
uncertain. Brttckraann and Vertheimer (1947) and also
Lazarow (1949) have considered this, and although the
hypotheses proposed by both groups of workers ore attractive,
there is, at present, no means of deciding which, if either,
is /
is correct. It does appear that glutathione immobilisation
is a factor in the production of the diabetic condition.
The resemblance of dehydroascorbic acid to alloxan,
the lowered glucose tolerance and accompanying increase in
tissue dehydroascorbic acid in scurvy were all reasons for
interest in the results obtained by Patterson (1949) on
treatment of rats with dehydroascorbic acid. He succeeded
in producing permanent diabetes in rats by injecting dehydro¬
ascorbic acid. The diabetic condition was very closely
parallel in histological, biochemical and physiological
symptoms, complications, and response to treatment to that
produced by alloxan (Patterson and Lazarow, 1950; Patterson,
1951). Whether dehydroascorbic acid can produce diabetes
in other species was less certain. Princiotto (1951)
reported diabetes in rabbits, following dehydroascorbic acid
injection, but Banerjee, Belavady and Mukherjee (1953) have
not been able to repeat this work.
The use of alloxan, with a certain amount of success,
in the treatment of pathological hypoglyeaemie conditions
in humans, has been reported in a few instances (Talbot,
Crawford as id Bailey, 1943; Brunschwig, Allen, Owens and
Thornton, 1944; Conn and Hinerman, 1943), However, the
extreme toxicity of the drug, duo to its action in oroducing
renal failure will surely restrict its clinical use.
The /
The parallel between alloxan and dehydroascorbic acid
seems sufficiently great to warrant the speculation that
dehydroascorbic acid may be a factor in the aetiology of
human diabetes raellitus.
Clayton et al. (1954) published results of tie injection
of dohydro.ascorbic acid nethanolata in human subjects. This
appears to bo the first account in the literature of the
injection of dchydroascorbie acid into humans* These
authors did not, however, investigate the glucose tolerance
of the subjects after the injection. They recommended
caution in the use of de'nydroascorbic acid in human subjects,
in view of possible liver damage, such as they found in the
guinea-pig. Patients who received injections of debydro-
ascorbic acid complained of local pain at the site of the
injection, another reason to restrict the use of the oxidised
product in experiments on humans.
Despite the obvious undesirability of injection of
dehydroaseorbic acid into humans, it seems of paramount
importance to investigate the possible part that the vitamin
derivative plays in diabetes maHitus. Indirect evidence




The purpose of this investigation was the identification
of the factors responsible for the regulation of the dehydro-
asccrbic acid content of human blood. In the course of the
study, a method was devised by means of \/hich it was hoped
to supply further evidence of the existence of dehydro-
ascorbie acid in human blood plasma.
Blood from normal subjects, and from patients with
pathological conditions, was examined with regard to the
response to esrogenous dehydroascorbic acid. Investigations
in vivo and in isolated specimens of blood were carried out.
It was hoped to establish the identity of the regulating
factors, and the mechanism of their action in human blood.
 
hots; Throughout this section and the succeeding ones,
it has been found convenient to use the following abbrevi¬
ations.
AA = Ascorbic acid = "Reduced" ascorbic acid
DHA ~ Deliydroascorbic acid
DGA = Diketogulonic acid
Tot. AA = Total ascorbic acid - AA ♦ DHA + DGA
GrSH = Reduced glutatldonc
GSSG = Oxidised glutathione
1. ESTIMATION OF ASCOihlC ACID,
a. General Introduction.
Many methods of estimating ascorbic acid in pure
solutions and in various biological materials have been
proposed. These methods involve the use of such widely-
differing reagents as peri-naphthindanetrione hydrate,
potassium iodate and «t-c*'dipyridyl. Most workers have,
however, limited themselves to one or other of two basic
techniques, or to the many modifications of these techniques
which have been proposed at various times.
One method is based on the extreme ease of oxidation of
ascorbic acid, and the other on the capacity of its two
primary oxidation products, dehydroaseorbic acid, DHA, and
diketogulonic /
33.
cLLketogulonio acid, DGA, to form a stable, characteristic
hydrassone with 2s4 diiiiirophenylhydrazine. The first
method is used to estimate the reduced form of the vitamin^,
AA^and for ease of reference is termed the "indophenol"
value; the second technique measures total ascorbic acid.
Tot. AA, namely ascorbic acid, together with dehydroascorbic
acid and diketogulonic acid. This is termed the "Roe"
value. The concentration of oxidised ascorbic acid in the
material under examination is determined by subtraction of
the result obtained using the first estimation procedure
from that obtained by use of the second.
DBA + DGA « Tot. AA - JUL
b. Oxida'idLoni-Reduction Method.
i. Introduction.
The most commonly used reagents in this method are two
redox indicators. Tillmans (1930) introduced the use of
2:6 diciilorphenolindophenol; the use of methylene blue was
first advocated by Martini end Bonsignore (1934). Despite
the greater sensitivity of the latter, indophenol is the
preferable reagent, since it is more easily manipulated and
is not light-sensitive, as is methylene blue. The method
used in the investigations reported here is that described
by Stewart, Horn and Robson (1953); a modified form of the
method proposed by Bessey (1933) is also used for much of
the experimental work. This incorporates sodium citrate as
buffering /
buffering agent, a procedure found to be more convenient
than the use of acetate, recommended by Mindlin and Butler
(193S).
When the dye is added to an ascorbic acid solution,
the pink colour noxvually exhibited in acid media is dis¬
charged. Hie discharge of the colour follows Beer's Law.
This has been adapted for apectrophotometrie estimations by
adding excess dye to the ascorbic acid solution and then
measuring the residual colour in the solution. Other
substances cause fading of indophenol, but the aeeolorisation
so produced takes place at a slower rate than that due to
ascorbic acid. Reading of the residual colour at a fixed
interval after the addition of the dye reduces the magnitude
of the errors due to the presence of other substances
reducing indophenol. The fading due to other substances is
very much reduced if the hydrogen ion concentration of the
solution is adjusted to a pH value between 3 and 4, By
adjusting the pH to within this range with sodium citrate,
the need to read the residual colour within the fixed
interval is not so great, and so technical manipulations
are easier. for convenience, the procedure in which sodium
citrate is used is termed the "buffered" estimation method.
The "unbuffered" estimation method is that in widen indophenol
is added directly to the acid filtrate of tissue, and the
residual colour is read at a fixed interval after mixing,
ii. Method /
35.
11' Me.vhau. feed in Satiat&tlun of Ascorbic Acid in Auuaoua
Solution. Serum and Plasma,
5sasm£s*
3% (w/v) aatsphosphoric acid. This was freshly made
for each series of estimations.
Dichlorphenolindophenol solution. Thi3 was prepared
by dissolving a "Dichlorphenolindophenol B.D.H." tablet in
water, filtering and making the volume up to 50 ml.
10$ (w/v) sodium citrate.
5% (w/v) sodium citrate.
lOOng./lOOml. ascorbic acid,
A standard curve was prepared from dilutions of the
ascorbic acid solution. The most convenient dilutions were
found to be 0, 0.25 , 0.50, 1.00, 1,50 and 2,G0rag./l00ml.
ascorbic acid. These standard solutions were submitted to
the sane process as that outlined below for plasma, as
rapidly as possible after the preparation of the original
lOOmg./lOOml. solution.
Procedure;
4.0ml. plasma, serum or aqueous solution were gently
mixed by inversion with 6.0ml. aetaphosphoric acid, centri¬
fuge! and filtered. In order to obtain a clear filtrate,
Whatman No. 42 paper was sometimes needed for filtration.
In the "unbuffered" estimation method, 2.0ml. of the
plasma filtrate or standard solution-acid mixture were mixed
with /
Table 1
Standard curve for "unbuffered" indophenol method
for reduced Ascorbic acid
Aocorbic acid Transmission reading







Standard curve for "unbuffered" indophenol method
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Standard curve for "buffered" indophenol method
for reduced Ascorbic acid
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Standard curve for "buffered" indophenol method
for reduced Ascorbic acid
ASCQBBIC ACID
with 1.0ml. 2*6 diehlorphenolindophenol solution and the
residual pink colour read 30 seconds later at 520r<«i» in a
Unicam SP 500 or SP 600 spectrophotometer. The filtrate
was read within 3-4 hours after preparation, otherwise decay,
occurred, with subsequent errors in the estimation. Reading
the standard solution filtrates against the indophenol
solvation resulted in the "standardisation* of the indophenol.
The use of the standardised indophenol solution with the
plasma filtrates permitted immediate estimation of the
ascorbic acid concentration of the latter. Table 1 and
Figure 1 show the standard curve for this method.
Using the "buffered" estimation method, 2.0ml. of the
standard solution acid filtrate were mixed with 0.5ml, 10%
sodium citrate solution before addition of indophenol. For
plasma, 2.0ml. of plasma filtrate were mixed with 0.5ml. %
sodium citrate and then indophenol was added. A pink colour
of considerable stability was obtained in this way, and this
could be read with accuracy at least two minutes after the
addition of the indophenol. A correction for turbidity was
made by decolorising all the solutions completely after they
had been read, and subtracting the blank values so obtained
from the original reading. The standard curve for the
"buffered* method is shown in Table 2 and Figure 2.
The reproducibility of the results was tested. The
mean result when 15 "unbuffered" determinations were carried
out /
out on a specimen of plasma for AA, was 0.69i0.02mg./l00ml.,
the range being Q.67-0.71mg./l00ml. Recovery of added M
was 100$. Similar results were obtained for the "buffered"
technique.
iii. Ascorbic Acid in Whole Blood.
Introduction;
Precipitation of whole blood with either raetaphosphoric
acid or trichloracetic acid, the precipltants normally
employed in ascorbic acid estimation, resulted in lysis and
release of haemoglobin. Lemberg et si. (1939) showed that
there is a coupled oxidation of haemoglobin and ascorbic
acid in the presence of cupric ions. AA estimations in
lysed blood, in which Gu++ ions from plasma were present,
were therefore invalid. These authors demonstrated that
carbon monoxide saturation prevented this oxidation, and
this resulted in the suggestion of Fujita, Ebihara and Numata
(1939) that whole blood should be saturated with carbon
monoxide prior to the estimation of ascorbic acid. This
was developed into a method for estimation of AA in whole
blood by Butler and Bushman (1940).
Method Used in Estimation of Ascorbic Acid in Whole
Bloods
A modified version of the method of Butler and Cushman
(1940) has been used in this work. Carbon monoxide was
generated by the action of sulphuric acid on dry sodium
formate and the soda- and water-washed gas was bubbled into
a /
a tonometer containing the specimen of blood. The tonometer
was rolled on its side during the procedure to aid thorough
saturation. The length of time required for the passage of
the gas was found to depend on the quantity of blood, but it
was usually found adequate to allow 10 minutes for every
20ml. blood.
Reagqnts;
6% (w/v) metaphosphoric acid. This was freshly made.
Dichlorphenolindophenol solution.
5% (w/v) sodium citrate.
Procedure*
6.0ml. metaphosphoric acid were added to 4.0ml. CO-
-saturated blood and mixed thoroughly with a glass stirring
rod to ensure complete protein precipitation. After standing
15 minutes, the mixture was centrifuged and filtered through
a Whatman No. 42 paper. Estimation was carried out exactly
as in the "buffered" method for ascorbic acid in plasma.
The reproducibility on ten determinations was determined.
The range was found to be 1.23-l»40mg./l00ml., with a mean
value of 1.31i0.06sng./l00ml, Recovery of added AA was 99%.
iv. Ascorbic Acid in Erythrocytes.
Introduction;
A completely satisfactory method for estimating ascorbic
acid in erythrocytes «ras not successfully devised, unless the
concentration of reduced ascorbic acid was very high. Most
work /
work done in the course of this study involved estimations
on erythrocytes with such concentrations, and for these a
satisfactory procedure was developed.
Method Used in Estimation of Ascorbic Acid in
Erythrocytes:
Reagentp:
6% (w/v) metaphosphoric acid. This was freshly made
for each set of estimations.
Dichlorphenolindophenol solution.
2.5% (w/v) sodium citrate.
Procedure:
1.0ml. erythrocytes, previously saturated with carbon
monoxide, was transferred by Pasteur pipette to a graduated
centrifuge tube and precipitation was carried out in this
tube with 6.0ml. raetaphosphoric acid. Thorough stirring
resulted in complete precipitation of the proteinsj after
standing 15 minutes, the mixture was diluted with 3.0ml.
water to bring the volume to 10.0ml, This results in a
1 in 4 dilution of the ascorbic acid. If the saturation
with carbon monoxide was complete, tho precipitate was a
red-brown colour, whereas a precipitate with a dark brown
colour was produced with erythrocytes previously untreated
with CO.
At the concentration levels of ascorbic acid investig¬
ated in this work, it was often found necessary to dilute
the /
the filtrate obtained from the above precipitation to an
even greater extent. This was done in the cuvette prior
to reading in the spectrophotometer, to give finally a 1 in
16 dilution. In such circumstances, 2,5% sodium citrate
proved t o be the most suitable buffer concentration.
The reproducibility with cells diluted 1 in 4 for 10
determinations was found to be good. The range was
0.80-0•94mg,/lOOml, with a mean of 0.87t0.05mg./l00ml.
v. ff^tim^tjon pf ftgcorbic Apid in Plapma afid Erythrocyte^
pf a Blood Specimen.
The specimen of blood was saturated with CO and then
centrifuged for 15 minutes. The plasma was separated, and
the requisite amount of erythrocytes transferred to a
graduated centrifuge tube. Precipitation of the proteins
in both components was carried out as soon as possible after
this. It was found that the process normally took 20
minutes to complete from the time eentrifuging was begun
until the proteins were precipitated.
For ease, the AA concentrations determined by this
method are termed alternatively "indophenol values" for AA
in the course of this report.
c. Use of Hydro :en Sulphide.
1. Introduction.
Hydrogen sulphide reduction has been used for many
years/
41.
yesr3 in the estimation of dehydroascorbic acid concentrations
in tissues and biological extracts. Tillmans et al. (1932a)
first applied it to lemon juice that had been oxidised with
iodine, and showed the restoration of the capacity of the
juice to reduce indophonol. Van Eekelen and her co-workers
(van Eekelen et al.. 1933) applied the treatment to trichlor¬
acetic acid filtrates of blood before testing for the presence
of the vitamin. Subsequently, Emmerie and van Bekelen (1934)
used HpS treatment in the course of their method for estim¬
ating the vitamin in blood. The reducing action of KpS
on oxidised lemon juice was confirmed by Johnson (1933).
He further pointed out the difficulty of removing the excess
HgS completely from such fruit juices. He also reported
the presence of traces of gas even after 5 or 6 hours of
treatment with wet nitrogen. He found, nevertheless, that
after three hours' treatment with nitrogen, the amount of
H2S left was insufficient to affect his estimations.
Hydrogen sulphide reduction has been widely used to
estimate the DBA concentration in tissues since 1933, but
there has been a tendency to underestimate the probable
errors attendant on its use. Apart from the difficulty of
removing the last traces of the gas, it is a relatively
unspecific reducing agent and its use may result in inter¬




It is difficult to assess the results obtained by
different groups of workers, owing to the wide variation in
the conditions used. There is little agreement on the
length of time necessary for the passage of H2S through the
filtrate. Authors also differ about the hydrogen ion
concentration of the filtrate, as well as the method used
and the length of time taken to remove excess HpS.
Levenson, Rosen and Hitchings (1951) investigated the
reduction of DHA with H2S, and they claimed good recovery
from iodine-oxidised ascorbic acid solution in glycine-HGl
buffer. they recommended HgS treatment for 10 minutes at
pH 3.19 and 376 j they claimed 94$ recovery of AA under
these circumstances. they gave no indication, however, of
the length of time for which they passed nitrogen to remove
excess H2S.
the method employed in this laboratory was substantially
that of Hochberg, Malnlck and Oser (1944).
ii. Method.
Reagents:
Antimony trisulphide, precipitated from tartar emetic.
2N HC1
Reagents for "buffered" ascorbic acid method.
Procedure!
A 5.0ml. portion of the plasma filtrate, prepared for
AA estimation, as described above, was buffered to pH 3.0-3.5
with /
•with sodium citrate solution. 1-2 drops of eaprylie alcohol
were added to prevent frothing. Pure H2S, generated by
heating antimony trisulphide with dilute H<XL, was bubbled
through for 10 minutes at 37°C. Wet nitrogen was then
passed through for 3 hours and the extrs.ct afterwards
filtered to remove any sulphur that might have accumulated.
Spectrophotometric examination with indophenol was then
carried out in the same way as described for the "buffered"
estimation for M.
Interpretation of the results obtained by H2S treatment
was always cautious owing to the difficulty of removing the
last interfering traces of the gas, and also to the unspec-
ific reducing action of hydrogen sulphide,
<*• Roe Method for "Total Ascorbic Acid".
Introduction.
This method is based on the formation of dinitrophenyl-
hydrazone of the primary oxidation product of ascorbic acid.
All ascorbic acid in the specimen being examined is oxidised
with "norit" charcoal and, together with any pro-formed
oxidised ascorbic acid, is converted to the dinitrophenyl-
hydrazone by treatment with dinitrophenylhydrazine.
According to Penney and Zilva (1943), the open-chain oxidation
product diketogulonic acid (DGA) is the substance which
reacts with the dinitrophenylhydrazine s the conditions of
the /
the reaction favour the rapid conversion of the lactone, DBA,
to its hydrated form, DQA. The concentration of phenyl-
hydrazone formed is estimated by photometric measurement of
the intensity of a red-brown colour produced on the addition
of sulphuric acid, Penney and Zilva (1945) report that
reductones and redact!c acid interfere with the estimation
and the original, authors, Roe and Keuther (1943) state that
aldehydes, ketones and high concentrations of sugars intro¬
duce a positive error. It is, however, believed that these
are relatively rare sources of error in human blood.
The results reported here as "total ascorbic acid"
(Tot, AA) have all been obtained using the method described
by Roe and Keuther (1943). It can be applied directly to
all cellular components of blood, and to plasma equally
satisfactorily since the oxidation of ascorbic acid on lysis
of the hlood does not invalidate the method,
ii. Method used in Estimation of Total Ascorbic Acid.
Reagent3i
6$ (w/v) trichloracetic acid.
21Idiaitroohenvlkydrasiae. 2g. 2:4 dinitrophenyl-
hydrazine dissolved in lOQui. 9® HpSO^. Filtered. Stored
at 5 C» Renewed every 2 months.
"Merit" charcoal. 200g. "norit" charcoal boiled with
1 litre 10j£ (w/v) HC1. Filtered with suction. Washed
with water until washings give a negative test for ferric
iron. /
iron. Dried at 110-120°G for 12-16 hours.
Thiourea. lOg. thiourea dissolved in 100ml. 50% (v/v)
aqueous alcohol. This reduces KM11O4 readily.
Sulphuric acid. 85% H2S04j prepared by adding 900ml.
conc. H2SO4 to 100ml. water.
lOOmg./lOOral. ascorbic acid.
Prococtaret
3.0ml. blood fraction or aqueous solution were nixed,
with vigorous shaking, with 9»Orrsl. trichloracetic acid.
After conurifuging, if necessary, the supernatant liquid was
decanted off, and approximately 700tag, "norit" charcoal were
added. This was shaken for 6 minutes in a mechanical shaker
and then filtered through a Whatman Ho. 42 peeper. 2.0ml.
filtrate were then transferred to another tube and a drop of
thiourea and 0.5ml. dinitrophenylbydrazine reagent added.
This solution was incubated for 3 hours at 37°G. The tube
was placed in an ice-bath and 2.5ml. 35$ II2SO4 were added.
H2SO4 was added slowly to prevent overheating in the tube.
Care was also taken to prevent HgSO^ coming in contact with
traces of thiourea which might have crystallised out on the
side of the tube. If this did occur, the final solution
was cloudy, and as a result photometric estimation was
inaccurate,
After the solution and added sulphuric acid had been
thoroughly mixed, the tube was allowed to stand at room
temperature /
Table 3
Standard ourve for Boe raethdd
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temperature for at least 30 minutes, before estimating the
intensity of the brown colour. This was carried out
photometrically using a Unlearn SP 300 or SP CQQ spectro¬
photometer, reading at 520m)i.
A standard curve of the brown colouration was prepared
by diluting lOOmg./lOOral. ascorbic acid solution to give
solutions of 0.25, 0.5, 1.0, 1.5 and 2.0ag./lOOml. and
submitting these dilute solutions to the procedure outlined
above. Table 3 and Figure 3 show the standard curve.
In calculating the results, a blan3: value was subtracted '
from the readings for both standard solutions and test
solutions. Has blank was obtained by using 2.0ml. 4.5$
GGI3COOH in the above procedure, in place of 2,0ml. of the
standard or test. Small variations in the standard curve
were observed at various times. Their cause was not
ascertained, but in view of their occurrence a standard
curve was prepared for each group of estimations.
Results obtained by this method were of good reproduc¬
ibility for whole blood and for blood constituents. Estim¬
ations of concentrations greater than 0.25ng,/l00ml, were
regarded as reliable.
Reproducibility in plasmas 18 determinations. Range,
0•42-0,51mg./l00ml, Mean, 0.44^0,Q3mg./l00al. 100$
recovery of added AA.
Reproducibility /
Reproducibility in bloods 10 determinations. Range,
0.48-0.64mg,/l00al, Mean, 0.5pt0,04rfig,/l00ml» 100%
recovery of added AA.
Reproducibility in erythrocyto.es 15 determinations.
Range, 0,72-0.85»g./l00ral. Mean, 0,8lt0,05mg,/l00ml.
g.^TIMATION OQLtlgATHIOKft.
a. Introduction,
In the course of the work for this thesis, it was
necessary to estimate the concentration of glutathione (031!)
in certain experiments. The method used was that employed
by Bhattacharya, Stewart and Robson (1955). This was a
modification of the classical method of Woodward and Fry
(1932).
The blood under examination "was lysed with sulpho-
saliqylic acid and the proteins simultaneously precipitated.
The soluble sulphydryl compounds - in effect C-3K and its
oxidised form, GSSG - were released into solution End the
precipitated protein was filtered off. The tripeptide was
then estimated by iodate titration.
b. Method Used in Estimation of Glutathione.
M eulphosallcylie acid. 25% (w/v) sulphosailcylic acid
3% (w/v) 3ulphosallcylie acid.
4$ (w/v) sulphosalicylic acid
«/
k/lOOO KIO3. 9»2ral. M sulpho3alicylic acid were
diluted to 90ml» approximately. 1 ml. 0.1M KIO3 was added
and the volume made up to 100ml,
% (w/v) ICE.
1% (v/v) starch solution.
Procedurei
3.Oral, whole blood were slowly added dropwise, with
shaking, to 12.0ml. 3% sulphosallcylic acid. Thorough
shaking was followed by centrifugation. The mixture was
then filtered through a Whatman Mo, 1 paper.
1.3ml. 4% sulphosalicylie acid and 1,3ml. KI were added
to 5.0ml. filtrate. Just prior to titration, 3 drops of
starch were added and the mixture titrated against M/lOOO
KIO3, The iodate was run in from a micro-burette until a
permanent, very faint blue colour was obtained.
Calculation:
Blff0ttygaaag x 100 « ng.OSH/lOOml. blood.
Burette jading x 10 - mg.GSH/50ml. filtrate.
3. FIUSPABATION OF DEMYDRQASCORBIC ACID,
a. Introduction.
ERA solution was used in much of the experimental work
for this thesis. A rapid reliable preparation was necessary
and that proposed by Patterson (1950) proved satisfactory.
This /
This was a modification of the method originally devised by
Moll and Wieters (1936) and involved oxidation of an aqueous
M solution with quinona, the latter being dissolved in
ether.
b. Method.
500mg» M were dissolved in 10ml, water or isotonic
physiological saline. This solution was shaken for 15
minutes with 15al, ether, in which 330m.g, freshly sublimed
qtdaone were dissolved. After removal of the ether the
aqueous solution was washed 5 tines with lOrl, portions of
ether, end then residual ether removed by reducing the
press-arc within the mixture. The DBA solution prepared in
tills way was compared with the solutions obtained by oxidising
AA with iodine or bromine. Their relative stability and
their response to HgS reduction vers considered. There was
no difference in response between the preparations. On this
basis, it was decided to use the quinone-oxidlsed preparation
as tho esqierlstental material for this work#
RESULTS
RESULTS
PART I. THE EXISTENCE OF DSHYDROASCORBIC ACID IN HUMAN BLOOD
PLASMA-
Estimations of dehydroascorbie acid, as distinct from
reduced ascorbic acid, in human blood plasma, have always
been based on the increase in the indophenol reading; of the
filtrate after RgS reduction has been carried out. Sinco
this method is of doubtful reliability due to the non-specific
reducing capacity of HpS, it was considered desirable to
estimate dehydroascorbic acid by some other method.
It was decided to apply a technique devised by Mapson
and Ingram (1951) for use in plant extracts, employing Bsch.
coli. A strain, of this bacterium has been found capable of
reducing DHA and a suspension of this strain has been used
in this work. The bacterial suspension was incubated
anaerobically and under strictly controlled conditions with
the solution under examination; the reduction of DHA by the
bacteria was stopped by adding mataphosphoric acid, and so
the amount of AA produced could be estimated.
Method.
The suspension of Esch, coll was prepared as described
by Mapson and Ingram (1951) from a dried sample of bacteria
(NCTC 4450). Mapson and Ingram's (1951) estimation procedure
was slightly modified and is described below.
Reagents: /
Reagents:
Buffer 7$ (w/v) BPO3, buffered to pH 6.2 with 7$ (w/v)
NaOH. The hydrogen ion concentration was determined using
chlorophenol red end "bromocresol purple as external indicators.
25% (w/v) glucose solution.
Eftoh. coli suspension.
20% (w/v) metaphosphoric acid. This was freshly
prepared for each estimation.
Procedure:
A stream of wet nitrogen was passed through 5.00ml.
HPQ^-BaOH buffer, and 0.25ml. glucose at 35*0 for 10 minutes.
A drop of cspryiic alcohol was added to the mixture to prevent
frothing. 0.75ml. Each, coli suspension was then added,
followed by 4.00ml. of the plasma or solution to be tested.
Nitrogen was passed for 15 minutes more, the temperature
being maintained at 35°G, and then the reaction was stopped
by adding 1.00ml. 20% HPO3 to the reaction tube. After
centrifuging and filtering through a Whatman No. 42 paper,
estimation by the indophenol method was carried out in t he
usual way. The results were multiplied by factor (ll/l0) to
correct for the variation from the normal volume proportions.
The method was tested on aqueous solutions of DHA and
recoveries were carried out on plasma.
Results. /
Table 4
The reduction of dabydroascorbic acid in plasma













B.B. 1.05 1.16 1.17
S.B. 0.92 0.98 1.04
J.R. 1.14 1.28 1.32
M.G. 1.33 1.36 1.32
C.T. 1.02 I.04 1.16

















J.E. 0.98 1*01 0.94 1.00
D. 0.52 0.57 0.72 0.70
C.T. 0.25 0.46 0.40 0.44
B.B, 0.28 0.26 0,23 0.29
A.L. 1.23 1.37 1.35 1.41
L.T. 0.15 0.29 0 • 28 0.25
Mean 0.57 0*66 0.65 0.68
Results.
The method, was applied to specimens of plasma from
volunteers and the results obtained were compared with those
for reduced AA and for Total AA. Some estimations were
carried out using sodium citrate buffer and others without
buffering the filtrates? in the latter series, estimations
after HpS treatment were also made. The results for both
series are quoted in Table 4.
Dificupgion.
The mean difference between the Roe and indophenol
values for the results quoted was O.llrag./lOOral, in both
sets of analyses. There was an increase in the indophenol
value after reduction of the plasma filtrate with HpS, the
level attained being that of the Roe value, if allowance was
made for the errors involved in the estimation procedures.
This suggested the difference between the two values was due
to the presence of EKA. Similar results were regarded by
Stewart, Horn and Robson (1953) as suggestive of the presence
of DBA in plasma.
Treatment of the plasma with the Ssch, coli preparation
resulted in an increased indophenol value in nearly all the
•specimens examined. The increase was such that the Indo¬
phenol and the Roe values were the same within experimental
limits after treatment with the bacterial suspension. The
Each, coli preparation had a specific reducing action with
regard /
regard to DHA. It seemed justifiable to attribute the
reason for the increase in AA concentration after bacterial
treatment to the reduction of DHA originally present in the
specimen.
This interpretation of the results inferred the presence
of some oxidised ascorbic acid in human blood plasma, in the
form of DBA, and was in agreement with the results from HgS
treatment. It confirmed previous reports of the presence
of oxidised ascorbic acid in blood plasma (Lloyd et al.. 1945;
Chen and Schuck, 1950; Davey et al.. 1952; Banerjee and
Belavady, 1953; Stewart et al.. 1953; Linlcsweiler, 1954.)
It was thought that the increase in indophenol values
after treatment with the suspension of S3ch. coli might be
caused by the buffering of the solution in the course.of the
estimation, said that it might not reflect cm actual reduction
of DBA. This is not so, however, as the increase in AA was
found after bacterial treatment of the plasma even when the
buffered indophenol estimation method was used. It there¬
fore seemed a valid inference that DHA did occur to a slight
extent in human blood plasma and was susceptible to reduction
by Bach, coli with a consequent increase in the AA concen¬
tration in the plasma.
Several hundred analyses of specimens of plasma were
carried out in the course of the experimental work for this
thesis using indophenol and Roe methods. The majority of
these /
these, from both healthy and ill subjects, were found to
show the difference between indophenol and Roe values,
attributed, for the reasons outlined above to the presence
of DHA, In no case was the concentration of DBA greater
than 0,25mg./l00!al. plasma and in most cases it was in the
range 0.05-Q*15mg*/l0Qml, plasma.
PART II. RSDOCTIOIi OF DEHYDROASCORBIC ACID IN HOMAHS.
!• Reduction la Vivo.
Introduction,
Earlier workers reported that administration of oxidised
orange juice resulted In an increase in tissue and urinary AA
concentration in guinea-pigs and humans (Johnson and Zilva,
1934; Borsook et al«. 1937; Todhunter et al.. 1950; De
Hitter et al.. 1951.) Thus, the existence of a biological
reduction mechanism for EHA was recognised. Experiments
were carried out in the course of this work to confirm these
findings, using ERA prepared in aqueous solution by quinone
oxidation.
Procedure.
Solutions of BRA were given orally to 6 adult patients
in the Royal Infirmary with various clinical conditions.
'10ml. portions of blood were removed by venipuncture with
paraffined syringes into oxalated tubes. The plasma ascorbic
acid concentrations were determined at various intervals after
feeding. Both AA and Total AA were estimated; the differ¬
ence between the values was attributed to the presence of
ERA, Determinations were made 30, 60, 120 and 180 minutes
after giving the DMA in each case, and in some of the cases,




Oral administration of dehydroascorbic acid


























60 0.95 1.04 0.09 0.91
120 0.95 1.04 0.09 0,91
180 0,88 1.00 0.12 0.88
300 0.79 1.01 0.22 0.79
1440 0.68 0.72 0.04 0.94
Patient B. (Normal)









60 2.54 2,55 0,01 1.00
120 2,50 2.50 0.00 1.00
180 2.00 2.10 0.10 0.95
300 1.38 2.10 0.32 o.9o
1440 1,14 1.51 0.37 0,76
The effect- of feeding Dehydroaseorblo acid
on the plasma Ascorbic and Dehydreasoorbic acids.
subject ] id. duodenal ulces
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DHA was prepared by quinone oxidation of ascorbic acid
and was given in aqueous solution.
Results.
The absolute changes in the plasma concentration of AA
and Total AA differed from patient to patient. The general
picture was, hot/ever, the same and a qualitative comparison
was possible. Two typical cases are quoted in Table 5 and
another represented in Figure 4.
Feeding ERA resulted In a sharp rise In both AA and
Total AA in the plasma. The ratio AAiTotal AA did not show
any appreciable alteration at any stage after administration
of the DHA. The ratios for all the cases examined are
quoted in Table 6. In all cases except No. 4, McD., who
was believed to be scorbutic, this ratio was never less than
0.76 and in most cases was considerably higher. The results
for MeD. were not reliable, since the methods of analyses
were inaccurate at concentrations of ascorbic acid less than
0.25mg./l00ml. and the plasma concentrations in this patient
120 and 180 minutes after administration of DHA were consid¬
erably less than this value.
Estimations for glutathione were carried out. In no
case was there a significant alteration in the concentration
at any time after feeding DHA.
Discussion.
Oral administration of DHA resulted in an increase in
both /
both AA and Total AA in the plasma, such that there was no
appreciable alteration in the ratio MiTotal M. This
indicated that little, if any, of the administered BHA
appeared in the plasma unchanged, but was reduced to M and
was estimated in that form. The responsible reduction
process was rapid since, 30 minutes after feeding, there was
a marked increase in AA and Total AA and the highest concen¬
trations were found 60 minutes after treatment.
The site of reduction of BHA and the extent of reduction
could not be determined by these experiments on unsaturated
subjects in vivo. Reduction might have occurred on the wall
of the alimentary tract or in the blood itself or in both.
. The increase in AA concentration in patient T, suffering
from rheumatoid arthritis, after an oral dose of 475mg. ERA,
was O.45mg,/l0Qtal. in one hour (Table 5.) In the normal
subject B, after the sane dose, there was an increase of
2.06mg./l00ml. in the same time. Patients suffering from
rheumatoid arthritis have been reported to saturate less
readily with vitamin C than do normals. This difference in
response to the vitamin appeared to be reflected with regard
to BHA in the results quoted in Table 5. Further consider¬
ation of the results did not, however, warrant this Inter¬
pretation. None of the patients examined in this experiment
had previously been saturated with ascorbic acid, nor was
there any knowledge of their previous dietary regime or
nutritional /
nutritional status.
The difference in response to administered DIIA might
therefore only indicate a difference in the previous nutrit¬
ional condition of the two subjects with regard to ascorbic
acid, and might bear no relation to their different physical
conditions.
The ri3k attendant on the injection of DBA to humans
was unknown, but it was considered inadvisable to inject it
into a healthy individual, in view of its proved diabetogenic
action in rats (Patterson, 1949). It was, however, admin¬
istered by intravenous injection into one patients this was
a woman with advanced carcinoma of the cervix who was already
moribund before the injection was given. The amount of DBA
given was very much less than wa3 used in the feeding exper¬
iments. DHA was prepared in a solution of isotonic saline
and was filtered through a Seits filter prior to injection.
As in the case of scurvy previously discussed, some of the
plasma values were suspect, since they were less than 0.25mg./
100ml. Nevertheless, the ratio AAiTotal AA appeared to be
significantly less than in the patients to whom DHA was fed,
suggesting that the DHA was appearing unchanged in the plasma.
This disagreed with the findings of Clayton et el. (1954) who
reported the appearance of AA in plasma after intravenous
injection of commercially prepared DHA. The physical
condition of the patient examined in this series was a
possible /
possible reason for the impaired ability to reduce DHA.
2* Sa&g&aa i,n s& la&aM Bioio^cai
(a) Bxistenca of the Reduction;
Iptpodiiatjo^.
Several workers (Borsook et al.. 1937; Schultze et al..
1937; Kinkawa, 1944) have reported that isolated animal
tissues and tissue breis reduced BRA. Whole blood and
erythrocytos have also been found able to reduce DHA (Schultze
et al.. 1937; Panteleeva, 1950; Lloyd, 1951; Lloyd and
Parry, 1954.) There are, however, no comprehensive accounts
in the literature of erythrocyte or whole blood reduction of
DHA. It was felt that further Investigation of the phen¬
omenon in humens was warranted, especially in the light of
its reported diabetogenic action in other species (Patterson,
1949; Princiotto, 1951.)
Leucocybes and platelets are reported to have a high
concentration of Total AA. Lowry, Bessey, Brock and Lopes
(1946) observed concentrations of 12mg./l00g. cells on a
daily intake of 23mg. of vitamin C, while on an intake of
78mg./day they estimated the leucocyte concentration to be
25mg./lOOg. cells. There does not appear to be any report
in the literature of work Which differentiated AA and DHA
concentrations in this fraction of the blood. Leucocytes
were reported to be able to oxidise AA to DHA (Lloyd, 1951.)
In/
MiSLl
Addition of dehydroaecor'cic acid to plasm and blood
Time
(tains)




































In view of the high Total AA concentration and the reported
oxidising capacity of this blood fraction, it was thought
desirable to remove the leucocytes as far as possible from
all specimens of blood before any investigations were carried
out.
Procedure.
The effect of the addition of DHA to plasma and to blood
was studied. The rate of decay was followed in both media.
Estimations were carried out for AA and for Total AA in
plasma; the effect of 00 saturation was considered by com¬
paring Total AA values after incubation with HIA in an
aerobic atmosphere and in a 00 atmosphere. GO saturation
permitted M determinations to be made on the erythrocytes.
A comparison was made between the addition of AA and of DHA
to whole blood.
liq&y&s-
Tables 7a and 7b show the plasma concentrations of AA
and Total AA at different times after the addition of 33EIA to
a) plasma and b) blood. The specimens were incubated at
37°C in all the estimations.
a) In plasma, Total AA measurements showed a quantitat¬
ive recovery of the added DIIA; AA estimations showed no
increase over the control value, the analyses being carried
out as soon after the addition of DIIA to the plasma as
possible. There wan a 20% fall in the Total AA concentration
in /
in 4 hours, and after 6 hours only 46% of the original DBA
remained. Meanwhile, AA estimations showed 10% formation
of a substance reacting towards indophenol in the same way
as ascorbic acid. Biological assay would be necessary to
establish if this substance was redxiced ascorbic acid.
b) MA was added to blood and the plasma separated off
at intervals by taking a portion of the blood at the requisite
time and centrifuging it. Analyses were then carried out
on the separated plasma immediately. In the example quoted
in Table 7b, only 40% of the MA added was recovered from
the plasma immediately after the addition of DHA,
[S2i§!
Packed cell volume of the specimen = 42%
. . Complete recovery of added DIIA = 17rag.Tot.AA/l00ml.
plasma
Actual concentration estimated = 6.75mg.Tot.AA/lQO
ml. plasma
• . Recovery from plasma of added DHA = x 100%
= 40% ]
Six hours after the addition of MA to the blood specimen
the Total AA concentration in the plasma was 15% of the added
DHA. AA estimations showed 33% formation of an indophenol-
-reducing substance six hours after the DHA addition.
It seemed improbable that 60,. of the added MA should
have been destroyed immediately after its addition to blood.
Total /
Table. 8
Bebydroascorbic acid addition to whole blood
a. Ho carbon monoxide treatment.
















Dehydrcascorbic acid added tc give concentration 10 rag./IGO ml. blood
15 0.24 8.64 13.8 10.7
ISO 1.87 3.30 18.0 9.2
360 3.58 3.90 15.4 8.5
b» Carbon monoxide treatment*











Total AA AA Total AA
mg/lOOEil mg/lQQtal rag/lOOml
(by calculation.)
Behydroascorbio acid added to give concentration 10 mg./lOQ ml. blood
30 G.#Q 4.26 20.6 25-7 5.8 10.1
120 1.20 2.79 21.6 20.9 6.7 7.7





























































































Total AA determinations vqtq therefore carried out on the
cellular portion of blood after the addition of BKA. The
results of one such experiment are detailed in Table 3a.
The concentration was found to be high and, when expressed
In terms of mg./lOOml. blood on the basis of the PCV of the
blood, gave, together with the concentration in the plasma,
a quantitative recovery of the added DHA.
Carbon monoxide saturation of the blood prior to the
addition of DIIA made possible the estimation of AA in the
cellular portion of the blood. Accordingly, a specimen of
CO-saturatcd blood, to which BHA had been added, was analysed
at intervals after the addition; AA and Total AA measure¬
ments were carried out in the plasma and the cells. The
results are quoted in Table 8b. A high concentration of
AA was found in the erythrocyte portion U3ing this technique.
The distribution of AA and Total AA was calculated and the
results were expressed in mg./lOOal. blood on the basis of
the PCV.
The effect of the addition of ascorbic acid to blood
was compared with that of DBA. In the examples quoted in
Table 9, the examinations were carried out on red blood cell
suspensions washed with isotonic saline to minimise any
interference from endogenous AA and DflA. The difference in
response to the two forms of vitamin C was marked and
confirmed the report that, unlike the dehydro-form, AA did
not /
not enter the erythrocyte (HeineaaWW 1941; Golden and
Sargent, 1952.)
Discussion.
It therefore appeared that, after Its addition to blood
from which as many leucocytes end platelets as possible had
been removed, IHA passed rapidly into the erythrocytes and
was there reduced to a considerable extent. The AA so
produced then leaked slowly out of the cells. This confirmee
the reports in the literature. The first step in the process,
the passage of MA into the cells, seemed to involve active
transportation since it was so rapid, and also the concen¬
tration of ascorbic acid eventual!;/ attained within the cells
was much greater than in the supporting plasma medium.
The passage of AA out of the cells was, by contrast, probably
controlled by a diffusion mechanism, since it occurred much
more slowly. Alternatively, such passage of AA, into the
plasm might be the result of cellular damage, in view of
•the reports that AA did not pass out of the erythrocyte
(Heinemann, 1941; Golden and Sargent, 1952.)
The passage of DHA into the erythrocyte was not influ¬
enced by the atmosphere in which the reaction occurred.
The analyses for Total AA in Tables Sa and 8b showed clearly
that a large proportion of the added MA passed into the red
blood cell. The appearance of AA in the plasma in the
specimen examined without previous CO saturation was parallel
to /
to a similar appearance in the CO-saturated specimen, CO
saturation permitted technical analysis for M in the red
blood cell? but exerted no influence on the transport of
DHA across the cell membrane.
Since the cellular portion of blood was seen to be the
active element in the reduction of DM, it was considered
advisable to male© comparisons using specimens with the same
PC?, The PC? of all blood specimens examined was therefore
adjusted to as near 30% as possible by centrifuging and
removing either excess cells or plasma. 30% was an arbit¬
rary choice for ease of calculation and also for convenience,
as being attainable without undue waste of blood.
Comparison of results was only possible if the load of
DHA was the Same in all cases. The choice of a final DHA
concentration of lOmg./lOOml, blood was also fortuitous, but
since it proved convenient in subsequent work, it was not
thought necessary to use another concentration, except in
certain cases. Indication of these will be given in the
relevant sections.
(b) Reduction of DHA in Various Clinical Conditions?
Introduction.
There is en indication in the literature that tissue
reduction of DKA is affected by the previous condition of
the animal from which the tissues originate (Schroll, 1938j
Vinokurov and Silakova, 1944; Matusis, 1951; Parrot and
Gaaave, /
Gazave, 1951).
Comparison of the response in different specimens of
blood to added DHA was therefore attempted. A series of
adults in normal health wore used aa subjects; analyses
were also carriod out on several patients suffering from a
variety of conditions. The choice of the latter series of
conditions was determined by the supply of available patients.
Another group of analyses was compiled using diabetic subjects.
The production of diabetes in rats after DMA injection
(Patterson, 1949) aroused interest in a possible relationship
between DBA metabolism and human diabetes mellitus. If
such a relationship existed, it was thought that the reduction
of DHA by the blood of confirmed diabetic patients might be
abnormal.
The reduction of DHA was recognised to be a reaction
governed by the erythrocytes. It was therefore decided to
investigate the reduction in a condition where erythrocyte
metabolism was known to be grossly abnormal. Pernicious
anaemia is such a condition and there is the additional factor
that it responds clinically to treatment with vitamin B-g in
a short time and in a marked fashion. Investigation of the
reduction of MA in blood from patients with pernicious
anaemia, before and during vitamin Bxp treatment was therefore
carried out.
It /
It was originally intended to compare the rate of
reduction in different specimens using standard experimental
conditions. The PC? of all specimens was adjusted to as
ne*r 30% as possible, the specimens were all saturated with
CO and incubated in an atmosphere of the gas at 37°C. The
concentration of DHA In the blood was as near IQmg./lOOml.
blood as possible,, Estimations in cells said plasma could
not b e carried out in less than 20 minutes after addition of
the oxidised vitamin for technical reasons and it was found
in the large majority of cases, that reduction of DHA had
gone to its fullest extent in that time. Comparison of the
initial rate of reduction thus proved impracticable.
Comparison of absolute levels of ascorbic acid in cells
and plasma was not satisfactory. The reduction of DHA was
a property of the erythrocytes and the concentration of
ascorbic acid attained in this fraction after adding DHA to
blood was very high. Small variations in the erythrocyte
concentration in different specimens of blood introduced
large variations in the concentration of both forms of
ascorbic acid in this erythrocyte fraction. Small variations
in the concentration of DHA added to different specimens were
magnified by the factor 100/30 (ml. blood/ml. R3G) on passing
into the erythrocytes.
The most satisfactory means of comparison was eventually











































































































































































defined as "the percentage of added DHA which is reduced to
AA in whole blood, under standard conditions of PC?, initial
DHA concentration and time, in an atmosphere of CO, at 37*C."
Corrections could be made for variations in the concentration
of erythrocytes, and of added DHA, using this means of
comparison.
The method of calculation is shown in Appendix I,
The percentage reduction of DHA was measured 30 minutes
after the addition of the dehydro-form. Technical manipul¬
ations prevented estimations being made in a shorter time
after the DHA additions decay of the added DHA was still
negligible at this interval.
Procedure.
The blood, with the leucocytes removed as far as
possible and the PC? adjusted to 30y, was saturated with CO.
DHA was added to give a concentration as near lOrag./lOOsl.
blood as possible. The blood was then Incubated for 10
minutes in an atmosphere of CO at 37°C. It was centrifuge!
for 15 minutes in a M3E table centrifuge at speed 10. Pre¬
cipitation of the plasma and erythrocyte proteins was carried
out in the remaining 5 minutes.
Results.
Blood from a series of subjects in good health was
analysed arid the results are given in Table 10, The percent¬
age reduction of DHA was calculated in each case, using the
method /
To© variation in the poroeatnge reduction of /tebydroaaoorbio acid
in "blood frott normal and pathological condition®.
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method outlined in Appendix I. The range of results for
the percentage reduction was found to be narrow for this
series of 10 people. Range ~ 46-55$. The mean value was
found -bo be 48.8$. The scatter of results is shown in
Figure 5a.
The percentage reduction of DBA in blood drawn from
patients suffering from a variety of conditions was then
considered. The results in Table 11 were obtained from
examinations carried out on various unrelated conditions.
One patient examined, J.MoD., was suffering from rheumatic
fever in which abnormal metabolism in the erythrocyte might
have been expected. As far as is known, there was no BBC
abnormality in any of the other conditions examined. The
range of values for the percentage reduction was very much
wider than that found for the normal subjects, as can be seen
in Figure 5b.
10 diabetic patients were used as subjects aid the
percentage reduction of DHA for each specimen is quoted in
Table 12. The scatter of values is shown in Figure 5c.
The mean percentage reduction of DMA was found to be 57$ for
this group, and the range to be 38-70$.
The fourth group of patients examined were those suffer¬
ing from pernicious anaemia. Only 8 subjects could be
examined, since most patients admitted into hospital had






















































































































































































not suitable for this survey. All the patients were examined
prior to clinical treatment? the mean percentage reduction
was found to be 67%, with a range 45-83%. The results are
listed in Table 13 and Figure 5d. One subject, J.W., was
not anaemic, but was included in this 3ories because he was
receiving vitamin Bi2 treatment. He was diagnosed to be
suffering from subacute combined degeneration, a neurological
condition usually associated with pernicious anaemia. He
responded clinically to •'vitamin therapy,
10Q(f»of "Oytoraen" was administered daily in most cases.
/
Analyses were carried out after "Gytawen" treatment was
commenced and the results quoted in coluran 2 of Table 13 are
for the period whan the clinical response was maximal.
The maximal clinical response was assessed by the reticulo¬
cyte count. In one ease, M.A., one pint of glucose citrate
dextrose blood was transfused as a preliminary to other
treatment. Vitamin B]_2 was then given as in the other cases,
In the ease of I,L», no treatment with the vitamin was used.
Although the patient was diagnosed to be suffering from
pernicious anaemia, sternal puncture showed a normoblastic
marrow and she was therefore regarded as being in natural
remission,
Each patient was examined a few days prior to discharge
from hospital end the percentage reduction of DM found in
these estimations is quoted in column 3 of Table 13,
There /
There is no figure corresponding to a period of maximal
response in the oases of J.W. and I.L., since the former
showed no marked reticulocyte response, and the latter
reoeived no "Cytamon1' treatment*
Discussion,
Interpretation of the results obtained with these four
groups of subjects can only be tentative. The percentage
reduction value of DiiA for a normal subject appears to fall
within a narrow range; age and sex do not appear to influence
the value of the ratio.
Infections are possible reasons for a change in the
reduction percentage. let, J.McD,, Table 11, with a diag¬
nosis of rheumatic fever, and on salicylate therapy, does
not show a strikingly lowered percentage reduction. There
are no grounds to regard the value, 41%, as abnormal.
Abnormal values would not be ©urprising in conditions with
an aasooiatau erythrocyte dysfunction. None of the condit¬
ions for which resoles are quoted in Table 11, however, are
expected to show such a dysfunction (Duncan, 1952) yet the
reduction percentage values are scattered over a much wider
range than is found for healthy subjects. Complete haeta-
atological data vm not obtainable for these subjects.
There seems to be a tendency for the reduction percentage to
be greater than normal as tho percentage haemoglobin rails
below the normal. At present this is only a tentative
interpretation /
Interpretation of the results.
Conclusions from the results for the series of diabetic
patients are even less definite. In view of the action of
injected DHA in rats, it seemed of interest to determine if
an impaired erythrocyte reduction of MA existed in human
patients suffering from diabetes mellitus. A possible
hypothesis is that such an impairment in reduction would
result in an accumulation of EHA in the circulation and a
consequent development of diabetes. Whether such a situation
does exist is, of course, not known, but the results obtained
for the percentage reduction of MA in the blood of human
diabetica make it seem very unlikely. In all but one case
the results either lie within, or are higher than the normal
range. The range of values is very much wider than that for
the normal series. There does not appear to be any parallel
between the severity of the diabetic condition, judged by the
insulin dosage of the patient, and the value for the reduction
percentage of DM. Whether there is any relation between
the latter and the state of insulin control is not certain,
but there is no evidence to suggest that any of the patients
were out of control at the time of the examinations. There
is no inverse relationship to be observed between the haemo¬
globin concentration and the percentage reduction value for
DHA in this group.
The haemoglobin concentration, or more accurately, the
packed /
packed cell volume of the blood under examination appears,
however, to be related inversely to the percentage reduction
of OKA values in the cases of untreated pernicious anaemia
examined. The severity of the disease, assessed by the
lowering of the PCV, appears to be directly related to the
percentage reduction. In some specimens of this group, a
fall in the percentage reduction occurs at the period of
maximal response, but this is not found with all the cases.
Examinations carried out prior to discharge of the
patients from hospital showed that none of the specimens had
attained a normal percentage reduction of ISIA, There was
no appreciable decrease in the percentage reduction corres¬
ponding to the marked increase in the PCV observed in all
the anaemic patients receiving "Cytamen" therapy. There
was no parallel between the haemoglobin concentration values
and those for the DHA reduction percentage.
While the clinical response to vitamin is observed
in a very short time, usually 3-3 days after commencement of
treatment (Duncan, 1952), the fundamental abnormality is not
completely corrected for a considerably longer time. The
life of a normal circulating erythrocyte is about 120 days.
It is reported that in untreated pernicious anaemia there is
a shortened RBC survival time which becomes normal once
treatment is commenced (Singer, King and Robin, 1948.) It
may be assumed that a large proportion of the erythrocytes
circulating /
circulating in the body for at least a month after the
commencement of treatment with vitamin are erythrocytes
which were in the circulation before treatment was commenced.
Treatment with vitamin promotes normal erythropoiesis,
but has no effect on the RBCs already released into the
circulation. These still influence the behaviour of the
circulating blood. In view of this, an initial abnormally-
elevated percentage reduction for DHA may not be expected to
fall to the normal range rapidly. In some specimens a fall
in the extent of the reduction was observed after a period
of treatment, but this decrease was never large. In case
M.A., the transfusion of one pint of normal blood, and the
resultant rapid lowering of the concentration of abnormal
cells, was a possible contributory factor to the decrease
in the percentage reduction in tills subject.
All the estimations tabulated in Table 13 were therefore
carried out while the erythrocyte conditions were still
abnormal, although a marked clinical improvement had been
observed. Determinations carried out after some months of
vitamin therapy should be of interest, as the gross
abnormality responsible for the anaemic condition should by
then be considerably, if not completely ameliorated. Such
examinations have so far not been carried out, but it is
hoped that they may be conducted in the near future. In
cases of pernicious anaemia, which are in complete remission
after /
after several months of vitamin therapy, erythropoiesis
3hould be normal as should be the circulating cells. It
seems reasonable to expect in such cases that the percentage
reduction of DBA should also be normal.
The conclusions to be drawn from the examination of the
reduction percentage values of BRA in normal and pathological
human blood seem to be as follows:
1) In blood from normal subjects in good health, there
Is a percentage reduction value for DHA of approximately
50$. The range is narrow.
2) A variety of completely unrelated conditions can
cause an elevation in the percentage reduction value. In
several diseases, the rise in this value appears to be
related inversely to the packed cell volume or to the
haemoglobin concentration of the blood under examination.
This appears to be particularly marked in untreated Addisonian
pernicious anaemia. Treatment with vitamin B^2 appears to
disrupt this relationship.
3) Haemoglobin concentration does not seem to be a
controlling factor in the cases of diabetes examined.
Neither the severity of the diabetic condition nor the state
of insulin control appears to influence the level of reduction
of DBA.
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PART III. MECHANISM OF THE REDUCTION OF DHA BY HUMAN BLOOD.
Infoofoct^on.
The reduction of DHA by tissues has been recognised to
be due to sulphydryl substances (Barron et al.. 1936a;
Borsook et al.. 1937; Schultze et al.. 1937). Schultze
and his colleagues (Schultze et al.. 1937) attributed the
reduction of ERA in whole blood to the presence of GSH in
that medium. P anteleeva (1950), Lloyd (1951) end Lloyd and
Parry (1954) confirmed the reduction of DBA by blood but
advanced no evidence about the identity of the hydrogen
donor. Reports in the literature showed that the reduction
in tissues did not fit the theoretical equation
DHA ♦ 2GSII = AA + GSSG
and supplementary or alternative reduction mechanisms were
postulated (Borsook et al.. 1937; Kinkawa, 1944.) There
does not appear to be any report of experimental investig¬
ation of the mechanism of the sttlphydryl reduction of DHA
in blood. An attempt has been made in the course of this
study to identify and characterise the responsible mechanism.
Certain information concerning it has been accumulated.
All analyses in this section were carried out using
blood withdrawn from a patient with haemochromatosis, who
was not, however, diabetic. This patient, D.R., whose blood
was found to reduce DHA to the same extent as that of a
normal subject (Table 11), reported to the Royal Infirmary
for /
for weekly examination. At each visit one pint of blood
was withdrawn by venesection using a heparinised outfit.
The blood was stored at 4*C in a bottle containing heparin.
No preservative was added. Determinations were never
carried out on blood older than 7 days, in the course of
these experiments.
In the investigations, DHA was added to various prepar¬
ations of blood or blood constituents, U3ing different
experimental conditions which are detailed in the relevant
sections. Unless otherwise stated, a concentration of
lOmg.DHA/lOOml. blood was used. The extent of reduction
was evaluated by the amount of AA produced in the reaction.
1. Lpca,tion of tfte Reducing Meohanipm.
Introduction.
The work outlined in Part II makes it abundantly clear
that the reduction of DHA in blood is accomplished by the
erythrocytes. The effect of haemolysis of blood on the
reduction was studied. Haemolysod blood was centrifuged
and the supernatant was examined for its reducing capacity.
Procedure.
A specimen of blood was centrifuged, the leucocytes
removed and the specimen saturated with CO. A portion was
then haemolysed by shaking with saponin and the reduction of
DHA in this portion was compared with that in an unhaeraolysed
portion /
Table 14
The addition of dehydroaacorbic acid to haemolysed blood
Specimen AA produced
(mg./lOQml* blood)
15 min. 30 min. 60 min.
Whole blood * 4.20 4.1? 4.10







30 min. 60 min*
1.42 I.50
1.36 1,42
portion of the same sarnie of blood. Table 14a shows the
results obtained.
Another portion of the same sample of blood was centri-
fuged to remove erythrocyte stroma and the reduction of DHA
was compared in the eentrifuged and non-centrifuged haemolysed
blood. Table 14b shows the extent of the reduction in the
two portions.
Results.
Haemolysis was found to diminish the rate of the reduc-
-
tion of DBA but did not affect the extent of the reduction.
The concentration of AA produced was unaltered by centri-
fugation of haeraolysed blood. It was concluded that the
reduction mechanism lay within the erythrocyte and not on
the wall of the cell. Haemolysis caused dispersion of the
reducing agent or agents and therefore slowed down the
reduction but did not alter the concentration of DMA eventually
reduced.
2. Extent of the Reduction.
Introduction.
The rate of reduction of added DHA within the RRC has
been shown to be rapid. The extent of the reduction was
found to vary, depending on the condition of the subject from
whom the blood was drawn. Even in normal subjects, an
individual variation was found in the amount of DHA reduced.
This /
Table 15
Effect of increase in dehydroascorbic acid concentration
on percentage reduction of dehydroaecorbio acid
























Tills suggested that the responsible mechanism became exhausted
and could not carry the reduction to completion. A specimen
of blood was examined to check the truth of this concept.
Procedure.
A specimen of blood was saturated with CO end DBA was
then added to give a concentration of lOmg./lOOml. blood.
It was incubated at 37°C. When reduction was apparently
complete, more DBA was added to raise the concentration of
DHA in the blood to 20mg,/l00ml. After further estimations,
subsequent increases in the DHA concentration were made to
30mg./l00ral. and then to 40mg./l00ml. and 50rag./l00ral. The
concentration of AA in the blood was estimated at each level
of DHA concentration.
Results.
The results are shown in Table 15. It appeared that
the absence of further reduction of DHA did not necessarily
indicate that the reduction mechanism was exhausted. Rather,
the reduction occurred to an extent characteristic of the
blood under examination and the percentage of DIiA reduced to
AA remained constant for that blood, regardless of the initial
concentration of the DHA added. This was true until high
concentrations of DHA were reached.
3* Identity /
Table 16
The effect on the reduction of dehydroascorbic acid










i 15 0.80 1.77
ii 20 1.37 1.97
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3. Identity of the Reducing Agent.
Introduction.
Evidence has been accumulated confirming the reports
that DHA reduction was brought about with -SH groups a3
hydrogen donors. Addition of soluble -SH donors increased
the extent of the reduction in blood. -SH inhibitors
prevented the reduction taking place completely.
a. Procedure.
A specimen of haemolysed blood was saturated with C30
and divided into two portions. Concentrated, glutathione
solution was added to one portion and the reduction of DHA
solutions of the same concentration was determined in both
portions, by estimating the AA produced after each specimen
had been incubated at 37#C for one hour.
Results.
Results are detailed in Table 16a. The addition of
GSII to blood increased the extent of the reduction of DHA
in that blood. There was also accordingly an increase in
the rate of reduction.
b. Procedure.
Solutions of GSH and cysteine hydrochloride were prepared
in which the concentration of sulphydryl groups was the same.
(Note; 157.5mg. cysteine hydrochloride and 307mg. glutathione
both contain 33.5mg. -SH.) Each was then added to a portion
of a specimen of blood, previously saturated with CO, to give
the /
the seme final concentration of -SH groups in each portion.
The reduction of DHA was followed in both, estimating the AA
produced in each specimen after one hour's incubation at
37°C.
&£££&&•
The results quoted in Table 16b showed that the hydrogen
donor was the sulphydryl group and the reducing capacity was
not a property peculiar to GSH,
c. Procedure.
A solution of egg albumin, prepared according to the
instructions given by Kekwick and Gannon (1936) was reduced
by electrolysis. A current of 60 railliomps. was passed
through a 2$ (w/v) solution of the albumin for 15 minutes.
The albumin solution, which gave a positive reaction with
sodium nitroprusside after reduction, showing that free -SH
groups were present, was then added to one portion of a
specimen of haemolysod, GO-saturated blood. The effect of
this addition on the capacity of the blood to reduce DHA was
then estimated. The incubation period was one hour at 37*0.
Results.
The result for one experiment is quoted in Table 16c.




The choice of an -SH inhibitor was limited by its effoct
on the estimation for AA. Alloxan and the only arsenito
salt available were both found to interfere with the indo-
phenol method, but the addition of iodoacatate or of certain
concentrations of cyanide had no effect on the estimation
procedure.
Cyanide is a relatively unspecific reagent inhibiting
several groups including —SSi. Iodoacetate is regarded as
a specific -SH inhibitor.
A portion of blood, after GO saturation, was divided
into two parts. The appropriate inhibitor was added to one
portion, and then JMk to both to give 10mg.DH&/100ml. mixture
The amount of AA produced after both portions had been incub¬
ated for one hour at 37°C was measured.
Results.
The figures listed in Table l6d showed that the addition
of -SH inhibitors to the reduction medium destroyed the
reducing capacity.
4. A Supplementary Reduction Mechanism.
Introduction.
Ascorbic acid in high concentrations was known to
interfere with the iodiometrie titration method of Woodward
and Pry (1932) for glutathione. Estimations of glutathione
by/
by tills method in blood to which DKA had previously been
added were therefore unreliable. Investigations were
carried out on such blood by Bhattacharya (1955) in this
laboratory using the glyoxalase method of estimation, employ¬
ing a manometric technique. These analyses showed clearly
that the reduction of DfIA in blood did not result in any
alteration in the concentration of blood GSH, There arose
the concept of some other agent in the human erythrocyte which
could also reduce added DMA, either independently of, or in
conjunction with the endogenous GSH.
a. Procedure.
A haeraolysed RBC suspension was prepared with erythro¬
cytes and water. After CO saturation, portions of the
suspension were diluted to different extents with phosphate
buffer at pH 7.4. The concentration of GSH having been
determined in the original suspension by means of the idio¬
mstrie titration method, it was possible to supplement the
diluted RBG-buffer mixtures with concentrated GSH solution
in order that the final GSH concentration in each portion was
the same. A very concentrated GSH solution was used in
order to minimise the decay of GSH prior to addition to the
blood mixtures. EKA was then added to all the portions to
give a final concentration of 10 iag»DHA/l0O ml, blood in each,
and the amount of M produced after thirty minutes1 incubation
at 37°Cwas estimated.
Table 17
Trie effect on dehydroascorbic acid reduction produced toy the increase
in KBC concentration, with a constant glutathione concentration
Estimated Results
(a) (b) (c) (d)
Proportion RBC Initial GSH Final GSH AA
suspension concentration concentration produced
{%) (mg./lOOml.5 (mg./lOOml.) (mg./lOOml.)
i 50 10.7 10.7 2.52
ii 33 8.8 7.0 1.50
iii 17 7 *3 5*2 0.75
i 50 • 6.1 4.6 1.32
ii 33 5.5 4.3 I.05
iii 17 6.1 3.3 1.00
i 50 12.5 11.9 1.97
ii 33 13.1 12.6 1.60
iii 17 14.1 11.6 1.30
i 50 11.4 9.2 2.03
ii 33 11*0 8.2 1.51
iii 17 10.9 8.7 1.13
Calculated Results
U) (f) (s) (h)
GSH loss Theoretical AA/lOOmg. Difference
GSH loss GSH
(mg./lQOml.) (mg./lOOml*) (mg.) (mg./lGOmg.)
i 0 8.8 23.6 •
ii 1.8 5.2 17.0 6.6
iii 2.1 2.6 10.3 6.7
i 1*5 4.6 21.6
ii 1.2 3*7 19.1 2.5
iii 2*8 3*5 16*4 2.7
i 0.6 6.9 16.6
ii 0.5 5.6 12.5 4.1
iii 2.5 4.6 8.0 4.5
i 2.2 6.7 17.8
ii 2.8 4*9 13.7 4.1
iii 2.2 3.5 9.6 4.1
Explanation of Calculations
Column ve) i Results in col.(b) - results in ool.(o)
Column (f) s Results in col.(d) substituted in theoretical equation(see text)
Column(^) : (Result in eol.id)/Result in col.(b)) x 100
Column xh) Col.(g)i - col.(g)ii. in Col.(g)ii - col. (g)iii
Figure 6
The relationship "between the concentration of the erythrocyte suspension and
the reduction of dehydroascorbic acid, at a constant glutathione concentration
tjrrf
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Results of several of these estimations are quoted in
Table 17. By means of the calculations detailed in the
table, a linear relationship was observed between the
proportion of erythrocytes in the suspension and the AA
produced for every 100 ag. GSH in the suspension. The
relationship is shown graphically in Figure 6, for each
experimental group. These graphs were all of the type
y - ax + b. This indicated that, given a constant level of
GSH, the reduction of BRA by an RBG-vnter suspension increased
with an increase in the proportion of RBCs present.
Positive errors in the estimation of GSR were probable
after incubation, due to the AA present in the specimen, and
this would produce a negative error in the estimation of GSR
loss. nevertheless the error was not large enough in any cf
the examples to be the complete explanation of the difference
between the actual values found and the theoretical values
for GSR loss based on the equation,
BRA + 2G3H = AA + GS3G.
This led to the conclusion that, an the concentration of
erythrocytes in a mixture increased, so less of the endogenous
GSH was used in the reduction of DBA. This corroborated the




The effect on dehydroascorbio acid reduction produced by dialysis,




































































1. ii Dialysed + QSH 9*5 7*7 0.84
iii Malysed 3.1 2*5 0,62
i Control 9.8 9.2 1.23
2. ii Dialysed + GSH 7*7 4*4 2.10
iii Dialysed 1.2 1.2 0.94
i Control 12.9 8.6 2.46
3. ii Dialysed + GSH 16.3 12.6 2.06
iii Dialysed 5*8 4.6 1.45
i Control 12.6 8.6 2.58
4. ii Dialysed + GSH 16.0 11.2 2.78
iii Dialysed 4*9 4.0 1.58
i Control 8.6 8.6 1.53
5* ii Dialysed + GSH 11.3 5.8 1.17



























Column (d) : Col«(c)ii - col.(o)iii
Column (e) J Results in col.(a) - results in col.(b)
Column ;f) s l)-~col(e)i ii}—col.(e)ii - col.(e)iii
Column (g)i: Results in col.(c)i substituted in theoretical equation,
BHA + 2GSH - AA + GSSO
Column (g)ii: Results in col.(d)ii substituted in theoretical equation
b. Procedure.
A haemolysed suspension of erythrocytes was prepared with
water and a portion of this was dialysed. Cold distilled
water was used to minimise the interference of cupric ions.
The duration of the dialysis ranged from 16 to 46 hours in the
different experiments. The rate of flow of the water in the
dialysis was 10 litres/24 hours. lodioaetric titrations
were carried out to determine the extent to whieh GSH had
disappeared from the dialysed suspension. The remainder of
o
the haemolysed suspension was kept at 4 G to be used as a
control. The volume of the control was adjusted with dis
water until the haemoglobin concentration in both it and the
■
dialysat© were the same. The haemoglobin was estimated
using the alkaline haematin method of Clegg and King (1942).
After saturation of both portions with CO, concentrated
GSH solution was added to a portion of the dialysed specimen
to increase the GSH concentration to a value approximating to
that in the control, DHA was then added to the specimens to
give a final concentration of 10 mg./lOO ml. in each and the
o
AA formed after 30 minutes® incubation at 37 C was estimated.
Iodiometric titrations for GSH were carried out on each of the
3 specimens before and after incubation.
Results.
Several experiments were carried out and the findings
are reported in Table 18. Dialysis lowered the GSH
concentration /
concentration very considerably, although complete removal
was not achieved on any occasion* There was the possibility
of a negative error in the estimation of GSH loss (cf. 4a
Results above), Nevertheless, the discrepancy between the
observed and theoretical values for GSH loss in the undialysec
samples was too great to be explained as experimental error*
The actual loss of GSH in the solution was very much less than
was expected on the basis of the theoretical relationship
between MIA and GSH*
The same was not true for the dialysed samples which had
been supplemented with added GSH, There was only a sraall
difference between the value found and the calculated valuo
for GSH loss and this was within experimental error. There¬
fore, in dialysed mixtures which had been supplemented with
GSH, tho loss of GSH during the reduction, of MA was that
expected on the basis of the theoretical relationship between
the two substances,
c. E£0csdu£2,
A haomolyaed suspension of erythrocytes, prepared with
water, was dialysed against running distilled water for 48
hours. After saturation with CO, part- of the dialysate was
reduced electrolytically with a current of 60 milliamps. for
10 minutes. A longer period of reduction was not possible
since the KOI bridge became completely blocked with REG
protein. It was assumed on analogy with plasma that the
reduction /
Table 19
lie effect on ieliydroaacorbic acid reduction produced by electrolytic
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U) e) (f) (g)
GSH loss Theoretical GSH loss Theoretical
GSH loss in ii and iii GSH loss
(mg./lOOml.) {mg./lOOml.5 (mg./lOOol.) in ii and iii
(mg./lOOml.)
i 0.6 0.7
ii 6.0 3.7 3.4 3.0
iii 6.0 5.7 3.4 5.0
i 0.5 0.7
ii 1.9 3.7 1.4 3.0






t Result in col





result in col. (b)
substituted in theoretical equation,
DBA + 2 GSH s* AA + GSSG
ii Result in cel.(d)ii - result in ool.(d)i
iii Result in col.(d)iii - result in cal.?d)i
ii Result in col.(e)ii - result in col. ^e)i
iii Result in col,,e)iii - result in col.(e)i
reduction liberated game, if not all, of the protein -SH
groups. Qualitative estimation with nitroprusside was out
of the question due to the colour of the suspension.
Quantitative estimation for liberated -SH groups was not
possible since all the methods for -3H groups so far investi¬
gated involved protein precipitation as a preliminary.
The reduced portion and another portion of the dialysate
were then supplemented with concentrated GSR to give the same
final G3H concentration in both. A third portion was used
as a control. Production of M from DHA added to the three
specimens was estimated, also the fall in GSH concentration
during the period of the reduction. The initial concentration
of DBA was 10 mg./lOO ml. in each specimen and the period of
incubation at 37%lasted 30 minutes.
iiepttUp.
The results for two experiments are given in Table 19.
The GSH lo3s from the specimens supplemented with the
tripeptide was the same in both cases. The production of
AA in the specimen which had been previously redueed eleetro-
lytically was greater than that in the unreduced specimen.
The loss of C-SH corresponding to the AA production, using the
theoretical equation as a basis of calculation, was therefore
greater in the electrolytically reduced specimen than in the
other. The I033 of GSH, expected on theoretical grounds,
exceeded the loss actually found in the reduced specimen to
an /
Tahle SO











The effect of temperature on

































an extent beyond the limits of experimental error, and
suggested that the liberation of free -SH groups on the
protein resulted in a lessened demaad for GSH in DHA reduction.




Portions of the same haeraolysed CO-saturated 30% RBC
suspension were incubated for 30 minutes with a concentration
of 10 mg./lOQ ml.DMA at several different temperatures. The
extent of the reduction was determined in each.
Results.
From the results expressed in Table 20 and Figure 7,
the Q10 (15° - 25°) of the reduction of EHA was found to be
1.12 below 30° C. Above 30° C, the temperature at which the
rate of the reduction was maximal, the (35° - 45°) was
calculated to be -1.43.
(b) Hydrogen Ion Concentration.
Procedure.
Portions of the same haemolysed CO-saturated RBC suspension
were incubated at different hydrogen ion concentrations. The
pH of the portions was adjusted using NflCl, N Na.OAc,
0.2M ny>04, or 0.2K Ha0H solutions. The reduction of DHA at
an initial concentration of 10 tag./100 ml. was estimated in
each specimen after 90 minutes* incubation at 37°C.
teilM /
Figure 8
The effect of hydrogen ion concentration































The effect of an increase in dehydroascoybic acid concentration
on the dehydroascorbic acid reduction in blood
MA concentration AA produced









The effect of dahydroascorbic acid concentration
on the extent of the reduction.
(mg./
100ml
DHA CONCENTRATION (mg. /100 ml. )
Figure 10
Graphical representation of Lineweaver and BurJc's i!934 equation
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Figure & shows the affect of the change In pH on the
rate of the redaction. The rate was maximal within the
physiological pH range, pH 7.4-7.6.
(c) DHA Concentration:
Procedure.
Portions of an erythrocyte suspension in water, with a
PC? approximating to 3Q£, were completely haemolysed and
saturated with CO. Each portion was incubated for 30 minutes
at 37°C at a different concentration of OKA, end the extent
of the reduction to AA was estimated.
Results.
The results are tabulated in Table 21 and plotted in
Figure 9. The Michaelis constant, K . for the reaction at* IB
this erythrocyte concentration was calculated using Lineweaver
and Burk's (1934) equation and was found from Figure 10 to be
12.5 mg./lOO ml. blood (0,0007 M), The calculation of the
equation and the derivation of Km are uhoun in *>pendix IX.
]&g£M2l£&«
Investigation of the reduction mechanism in blood with
regard to IKA resulted in the formulation, of the following
conclusions:
1. The reducing mechanism is located within the
erythrocyte /
erythrocyte,
2, The extent of reduction is characteristic of the
blood under examination and is independent of the iniHal
ERA concentration,
3, The hydrogen donor for the reduction is a sulphydryl
group, either in the form of a soluble -3H donor or as
"fixed" SH.
4, The extent of the reduction is directly proportional
to the erythrocyte concentration when the GiSH concentration
is maintained at a constant value,
5, Dialysis of blood either destroys or removes sons
factor concerned in the reduction of DBA,
6, Electrolytic reduction of dialysed blood partially
restores the reducing capacity lest on dialysis,
7, There is an optimal temperature of 30°C.
8, Hydrogen ion concentration influences the reduction,
the rate being maximal in the physiological pH range,
9, The rate of the reduction is proportional to the
initial ERA concentration, below a specific concentration.
Above this Ulk concentration, the rate is independent of the
concentration.
It has therefore been confirmed that the reduction of
MA Is controlled by -dp, groups; it has also been confirmed
that the reduction does not follow the theoretical relationsldp
DHA + 2C-SH - AA + GS3C-.
The /
The contributory or supplementary reducing mechanism
has been found to be associated with the erythrocyte. The
only sourco of -SH groups in the RBC other than C-SH is the
protein, either globin of haemoglobin or other protein
.
present in the .RBG, The sensitivity of the system to
temperature, to pH, and to dialysis, suggests that protein is
concerned in the reduction. The loss of activity upon
dialysis is not due merely to the removal of C-SK from the
blood suspension since addition of GSII to the dislysate does
reduction, such as any diphospho- or triphosphopyridine-
nucleotida present in the medium. Prolonged dialysis
probably also causes a certd n amount of protein denaturation,
including the oxidation of free -SH groups.
It therefore seems that the reduction of DHA is brought
about by endogenous GSH, the concentration of which is kept
arises whether the regeneration of GSH from GSSG is governed
enzyiaieally.
Roe and Barnum (1936) suggested that tissue reduction of
DHA was enaymically controlled, but the evidence they advanced
to support this hypothesis was subsequently discounted by
Borsook et al. (1937). Schultze et al» (1937) reported the
existence /
not restore the original situation. Dialysis removes other
factors of low molecular weight which may be concerned in the
constant by regeneration from an additional reductio
probably the fixed -SH groups of the RBG protein.
existence of a heat-stable reduoing mechanism for DBA in liver
tissue. Kinkawa's (1944) report of a heat-stable non-
enzymic DHA reduction mechanism in tissues has not been
confirmed in this study on blood. The evidence from the
present investigation ha3 shown that heating at 100°G
*
completely destroys the reducing capacity.
The evidence collected in this investigation suggests,
on balance, the participation of an enzyme or an enzyme system.
Protein is involved in the reaction and so the mechanism
exhibits many enzyme characteristics, such as response to
temperature, pH, and heavy metals. The Kffi is small in
value and the reaction is rapid.
Indirect support for the possible existence of an
enzyme system concerned with EGA reduction is found in the
report by Rail and Lehninger (1952) of an enzyme in rat
liver, glutathione reductase, which catalyses GS3G reduction,
with TPNHg as co-enzyme.
TPNH2 ♦ GSSG = TPN + 2GSH
This enzyme may be part of an enzyme chain responsible
for the reduction of DHA in blood. It has not however been
demonstrated to occur in human bloods also there is




The evidence collected in this report from work on
human blood agrees with the reports in the literature that
mammalian tissues, among them red blood cells, have a
reducing capacity with regard to added dehydroascorbic acid.
KRTTKROCYTS REDUCTION OF DEHYDROA3COREL G ACID.
The reduction of ERA in the erythrocytes is in the first
instance brought about by glutathione within the RBCs» The
GSH concentration of these cells is therefore a contributory
factor controlling the extent of the reduction. GSSG,
produced in the course of this reaction, is reduced again
aad so becomes available to reduce more ERA, It is still
not clear what mechanism is responsible for the regeneration
of GSH from GSSG.
1) GSSG may be reduced by means of an interaction with
one or other of the phosphopyridinenucleotides. Such a
reduction of GSSG by TPHH^ is reported to occur in rat liver
tissue, catalysed by the enzyme glutathione reductase (Rail
and Lehninger, 1952). This enzyme has not been found in
erythrocytes, but the possibility of its presence, or of a
parallel system, must be borne in mind.
2) Alternatively, GSSG may be reduced to GSH by direct
interaction with the fixed -SH groups on the erythrocyte
protein. /
protein. Since the reaction is sensitive to -SH activators
and inhibitors and also to protein denaturating agents, it
seems probable that the erythrocyte protein is involved in
the reaction. The mechanism of regeneration of such fixed
-SH groups, when they have been used in the reduction of
GS3G, is quite unknown,
3) A third possible means of regeneration of GSH might
be through the agency of a phosphopyridinanucleotide-enzymo
system (such as glutathione reductase-TPHH) which, in turn,
2
would accept hydrogen from protein -SH groups. Alternatively,
the steps in the reaction chain might be reversed, GSSG being
reduced by protein -SH groups, the latter being restored to
their original state by means of a "reductase" enzyme, in
conjunction with one or other of the phosphopyridinenucleo-
tides.
SIGh-irjc^Gd Q? laiyTiffLocyrg Rfflucxpg OF DWff^gaRBig Acp.
Although the reduction capacity of erythrocytes for DHA
has been demonstrated Tinder ia vitro conditions in an isolated
biological system, it is another matter whether it is justi¬
fiable to assume that the same response occurs and is
biologically important £& vivo.
In the experiments described earlier in this thesis,
the reduction of DHA by erythrocytes was examined and the
conclusions regarding the mechanism were reached with non-
physiological /
94,
non-physiological experimental conditions. An exceedingly
high concentration of DBA was used, far above that which
could occur naturally in blood; the blood was saturated with
CO; most of the leucocytes were removed prior to the
investigation.
The results in Table 21 and Figure 9 showed that the
initial rate of reduction of MA was a function of the
concentration of the added MA* The extent of the reduction
was independent of the initial DHA concentration when the
latter was greater than 50 mg./lOO ml, blood. Table 15
showed that in all cases, with MA concentrations greater
than 10 iag#/lOG ml. blood, the reduction was incomplete and
ceased even in the presence of considerable aaounts of GSH,
This was not due to exhaustion of the reducing mechanism,
since the addition of more MA to the medium resulted in the
production of more AA. Figure 9 showed, however, that at
very low concentrations of MA, such as might be found in
blood, the major portion of the added substance was reduced
to AA.
The use of a CO atmosphere was introduced for technical
reasons and had no influence on the behaviour of DHA after
addition to whole blood. The CO atmosphere prevented a
coupled oxidation of AA and haemoglobin when the cells were
lysecl, (Lemberg et al.. 1939), and so enabled the quantitative
estimation of AA to be made in whole blood. The results in
Tables /
Tables 3a and 3b showed that MA passed into the erythrocytes
equally as well in aerobic conditions as in blood previously
saturated with GO. Plasma analyses, quoted in these tables,
showed that M appeared in the plasma after DBA addition to
whole blood in an oxygen or in a CO atmosphere. Reduction
of MA was therefore realised to occur in blood, regardless
of the atmosphere in which the blood was maintained and by
analysis of the GQ-saturated erythrocytes, it was shown that
the erythrocytes were the active elements in the reduction.
leucocytes contain a high concentration of Total AA
(Lowry et si.. 1946). They are also reported to oxidise AA
to MA (Lloyd, 1951), and their presence in blood influences
the transfer of ascorbic acid across the blood cell membrane
(Heinemann, 1941). In light of their metabolic activity
towards ascorbic acid, it was therefore necessary to remove
them from all blood samples examined, in order that the
behaviour of the erythrocytes with regard to AA and MA could
be examined accurately.
Taking the evidence as a whole, there is every reason to
believe that the conclusions reached, using the non-physiologi¬
cal experimental conditions described, are valid also for the
conditions found in vivo.
The experiments in which MA was fed, of which details
were given in Tables 5 and 6, showed that administered DHA was
rapidly reduced within the body and so corroborated the results
obtained /
obtained by in vitro investigations# The reduction occurs
within the rod blood cells, but this does not preclude the
existence of sites of reduction in many other organs and
tissues# This is confirmed by the evidence of several
workers, including Todhunter et al> (1950) and Clayton et al.
(1954), from investigations carried out on human subjects.
mmmrnma t
The experiments in which plasma was treated with Esch.
coli suspension demonstrated that DliA is found in human blood
plasma. It is not invariably possible to detect or measure
it in specimens of plasma, but the great majority of samples
examined contained concentrations of ERA ranging from 0.05 -
0.25 mg./l00 ml. plasma. It did not at first seem possible
to reconcile the existence of IEA in the plasma with the rapid
reducing capacity of erythrocytes end other tissues for that
substance. These two seemingly contradictory conditions can
however be recognised to be complementary, by mesis of the
following hypothesis. In the construction of this, the
metabolism of the leucocytes with respect to AA and BHA is
taken into consideration. The leucocyte response to vitamin G




POBWWB) OF ASCORBIC ^ in iiui'ji BPOg.
Ascorbic acid passes into the blood from, for instance,
the small intestine during absorption after ingestion. It
is partly tsten up by the leucocytes end there rapidly converted
to DBA, ■with the loss of two hydrogen atoms. This may
possibly, although not necessarily, occur through the inter¬
mediate of tho free radical, monodehydroascorbic acid
(Weisaberger and LuValle, 1944), DBA then passes out of the
leucocytes into the plasma whence several route3 for its
utilisation and further metabolism are available,
1) It may pa3s into the erythrocytes and there undergo
reduction, the extent of which is characteristic of the blood
under consideration, Estimations of the reduction capacity
have been carried out on specimens of blood obtained from
normal healthy subjects, considerable periods of time elapsing
between two estimations on the same patient. It was found
that the extent of the reduction of DBA was relatively constant
for each individual, even if several months passed between
one determination and the next.
After MA has been reduced in the erythrocytes, the AA
produced passes out of the RBCs to a small extent. Part of
the AA remaining in the RBOs may be re-oxidised, possibly
through the monodehydroascorbic acid radical to DBA, and so
re-enter the GSH reduction mechanism.
2) Plasma DBA may be oxidised to CO2 and water. This
/
nay occur within the blood cells directly, particularly in
the leucocytes, or in some other body tissue.
3) DBA may remain in the plasma to be converted to DGA
and then finally to water and 00^. Estimations suggest that
this is, at most, only a minor route of IRA metabolism#
In normal conditions, the first pathway described for
the metabolism of the DBA passing out of the leucocytes seems
to be the only one of importance in its utilisation. In
such a mechanism there is a small concentration of DHA likely
to be present In the plasma, which will therefore be detect¬
able by H.,S or Bsoh. eoli reduction.
The second route is probably the chief means of
cataboliaing DBA in the body. A mechanism for oxidising AA
to water end GQg has been reported to be present in guinea-pig
liver by Stotz et at. (1937). A similar mechanism probably
occurs in human liver and other tissues.
The third pathway for DHA disposal is not thought to be
important normally. There is no evidence that DGA is a
component of human blood plasma in vivo. Penney and Zilva
(1943) presented results that indicated the appearance of a
small amount of DGA in guinea-pig blood plasma after feeding
abnormally large doses of MA, In the conditions found in
the ezperiraents on isolated blood specimens, where there is a
high concentration of added ERA incubated in a closed metabolic
system, the residual MA is probably converted in large part
to /
Figure HP
Diagrammatic representation of the behaviour























(4) Estimated by H0S or
Each. coli redaction.
to DGA as suggested by Lloyd and Parry (1954), A very
different situation prevails in vivo where other routes for
metabolising HIA, and many other complicating factors occur.
Figure 11 is a diagrammatic representation of the meta¬
bolism of M and DBA postulated above. This hypothesis is
recognised to be a crude explanation of the experimental
evidence. At present, no satisfactory account can be
developed for the abnormal behaviour with regard to DBA in
blood from patients with various pathological conditions.
It is realised that other routes may exist for the
utilisation and disposal of ascorbic acid in human blood in
addition to that outlined above. Plasma AA may be directly
oxidised to water and GO^, without passing through the inter¬
mediate step of KIAj alternatively, plasma AA may lose one
hydrogen atom to yield monodahydroasoorbic acid, and In this
form ontor many metabolic reactions,
PS liLGULpTIOp OF 4hP CC^TEATICfl
HUMAN BLOOD.
The factors in human blood which are therefore regarded
as responsible for regulating the DBA content of human blood
are;
1) the reduction capacity of the blood with regard to DBA
Tills is dependent on
a) /
a) the GSH concentration
b) the mechanism for GSSG reduction, in the BBC
the leucocyte concentration, and
the ascorbic acid load in the diet*
mm.
SUMMARY
1, Evidence has been presented, to confirm previous reports
in the literature that dehydroascorbie acid is a normal
constituent of human blood plasma. The estimation procedure
■
was a modification of one originally devised for use in plant
analyses, and had not previously been applied to animal tissues,
2, Oral administration of dehydroaseorbic acid solutions to
human subjects resulted in an increased ascorbic acid concen¬
tration in the plasma, and so confirmed the previous reports
of a biological reducing mechanism for dahydroascorbic acid.
The results obtained by incubating fresh isolated suspensions
of erythrocytes in plasma or saline with high concentrations
of dehydroaseorbic acid provided additional evidence of the
existence of this mechanism in erythrocytes,
3, The extent of the reduction of dehydroascorbic acid was
examined in blood from normal subjects and also from patients
suffering from a variety of pathological conditions. The
percentage of dehydroascorbic acid reduced to ascorbic acid
under standard experimental conditions was estimated in each
sample of erythrocyte-plasma suspension. The results obtained
thus could be compered. In normal subjects, the values for
the extent of the reduction were found to fall within a narrow
range, (46$ - 55$ of the added IEA), The range of results
was much wider in the various groups of pathological conditions
examined, /
examined. There wag a tendency for the extent of the
reduction to be inversely related to the haemoglobin concentra¬
tion of the original blood sample. This relationship was
most marked in the specimens from patients with untreated
Addisonian pernicious anaemia. Treatment of these patients
with vitamin did not result in a marked alteration in the
behaviour of the blood with regard to dehydroaseorbie acid.
The extent of the reduction of dehydroascorbic acid in
blood drawn from patients with diabetes raellitus could not be
related to the severity of the diabetic condition nor to the
state of insulin control of the patient.
4. A study has been made of the mechanism responsible for
the reduction of dehydroaseorbic acid in human erythrocytes.
The reduction is brought about in the first instance by endo¬
genous glutathione. The glutathione is maintained in the
'
reduced state, possibly through the agency of an enzyme system
and with the erythrocyte -SH protein groups as hydrogen donors.
The ultimate hydrogen donor is unknown. Glutathione reductase
and one or both of the phosphopyridineuticieotides are possible
components of such an enzyme system.
5. This reduction mechanism has been integrated into a
hypothetical representation of the metabolism of ascorbic and
dehydroascorbic acids in the leucocytes end erythrocytes in
human blood. The possibility that monodehydroascorbic acid
may be involved has been noted.
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Fa MTi™0D FnR ^T.niTLATIQN OF THS PJ
DEHYEROASCORBIC AGIO.
Symbol?.
Ascorbic acid, in plasma = (AA) plasma
Ascorbic acid, in cells = (aa)ceiis
Total Ascorbic acid, in plasma = (TotA)plasma-
Total Ascorbic acid, in cells ® (Total )cens
(AA) laaHa, expressed in mg./lOO ml. blood -
SaS&iatefl ggagaatea&ga .bk a UgLs^fifl
100
(AA) cells' expressed in mg./lOO ml. blood i
Sstirar-j.tprl pop?Gpt.r^ on AA X PPY.
100
(Total)piexpressed in mg./lOO ml. blood =
Bstiranta^ concentration TotA AA X, (100,J=JiS£)
100
(TotaL )C0Ha» expressed in mg./lOO ml. blood =
Estimated concentration Total AA X POT
100
(^blood 88 ^^plasma ^^cells
(Total)blood " (Total^plasma + ^TotiiL^cells
____. (AA),.
Percentage Reduction of JXLA = bloofl x 100
(TOti 'blood
A worked example, employing the calculation, followst
Sample /
Sample of blood (PCV = 30%), containing a final concentra¬
tion of 10 mg./lOO ml, blood ISA.
M, in plasma = 0.70 mg./lQO ml. plasma
AA, in cells 9 15.0 mg./lOO ml. cells
Total AA, in plasma = 5.71 mg./lOO ml. plasma
Total AA, in cells 53 20,0 mg./lOQ ml. cells
Calculation*
(AA)piagma 55 °»79 ^(1°° - 3&) mg./lOO ml. blood
- 0.49 mg./lOO ml, blood.
ii.
cells
15.0 x 30 mg./lOO ml. blood
100
4.50 mg./lOO ml. blood.
(AA)^ 38 (0.49 ♦ 4.50) mg./lOO ml, blood
« 4.99 mg./lOO ml. blood.
(Total)plasma = 5*2^02 »g./'l00 nl. blood
= 3.99 mg./lOO ml. blood.
(Totaling = ?0'°Qg % mS'/lOO ml. blood
- 6,00 mg./lOO ml. blood.
(Total)blood 33 (3*" + 6#00) ms'/W0 ml* blood
- 9.99 mg./lOO ml. blood.
percentage reaction of EflA = ^ * 100* = 49.9%9*99
mmm xl
m oy lwwmm 4^ aVftV? (1934) BWyup*
Michaelis equation i v
v = AA produced/30 min.
3 = ERA concentration.
K = Michaelis constant.
£1
V = Uniting concentration of
AA produced/30 min.
From this, Lineweaver and Eurk's equation can be
derived.































Lineweaver and Bark's equation J g = + £
From above table and graph in Figure 10,
U> = 5a ♦ & (1)
V V
20 = 5» + m*i (2)
V f
10V a K ♦ 50 (1)111
20V = Kffi + 112.5 (2)
V
Solution of these equations gives :
a 12.5 V = 6.25 mg,/30 min.
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